CN104818340B - Detect primer, kit and its PCR method of JAK2 gene V617F loci polymorphisms - Google Patents
Detect primer, kit and its PCR method of JAK2 gene V617F loci polymorphisms Download PDFInfo
- Publication number
- CN104818340B CN104818340B CN201510290700.3A CN201510290700A CN104818340B CN 104818340 B CN104818340 B CN 104818340B CN 201510290700 A CN201510290700 A CN 201510290700A CN 104818340 B CN104818340 B CN 104818340B
- Authority
- CN
- China
- Prior art keywords
- primer
- detecting
- probe
- primers
- housekeeping gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
技术领域technical field
本发明涉及分子生物学基因检测领域,特别提供了一种检测JAK2基因多态性的引物、试剂盒及其PCR方法,用于JAK2基因V617F多态性位点的快速检测。The invention relates to the field of molecular biological gene detection, and in particular provides a primer for detecting JAK2 gene polymorphism, a kit and a PCR method thereof, which are used for rapid detection of the V617F polymorphism site of the JAK2 gene.
背景技术Background technique
JAK是一种非受体型酪氨酸蛋白激酶,迄今为止共发现有4个家族成员,分别为JAK1、JAK2、JAK3和JAK4。STAT是JAK的直接底物,能将信号直接传递到核内,调节特定基因的表达。JAK-STAT信号通路是与细胞生长、增殖、分化关系十分密切的一条信号通路,也参与造血和免疫等系统的信号转导,而激酶JAK对整个信号通路激活起着关键作用。迄今已在人类白血病细胞中发现多种JAK基因点突变,其中一些突变能导致STAT蛋白持续激活。例如JAK2基因V617F突变可导致JAK-STAT信号通路的异常激活,导致骨髓细胞产生异常增殖。JAK is a non-receptor tyrosine protein kinase. So far, four family members have been found, namely JAK1, JAK2, JAK3 and JAK4. STAT is the direct substrate of JAK, which can directly transmit the signal to the nucleus and regulate the expression of specific genes. The JAK-STAT signaling pathway is a signaling pathway closely related to cell growth, proliferation, and differentiation, and also participates in signal transduction in hematopoietic and immune systems, and the kinase JAK plays a key role in the activation of the entire signaling pathway. So far, many JAK gene point mutations have been found in human leukemia cells, some of which can lead to the continuous activation of STAT protein. For example, the V617F mutation of the JAK2 gene can lead to abnormal activation of the JAK-STAT signaling pathway, resulting in abnormal proliferation of bone marrow cells.
骨髓增殖性疾病(myeloproliferative diseases,MPD)是一组造血干细胞肿瘤增生性疾病。在骨髓细胞普遍增生的基础上有一系或多系细胞尤其突出,呈持续不断的过度增殖和外周血中成熟细胞数量增多为特征。其临床表现具有异质性,但各亚型几乎都伴有白细胞、血小板及巨核细胞增多,后期出现骨髓纤维化和骨髓衰竭,随病程进展部分可转化为其他疾病。其经典的分类主要分为慢性粒细胞白血病(chronic myelogenous leukemia,CML)、真性红细胞增多症(polycythemia vera,PV)、原发性血小板增多症(essentialThrombocythemia,ET)以及原发性骨髓纤维化(primary myelofibrosis,PMF)等。Myeloproliferative diseases (MPD) are a group of hematopoietic stem cell neoplastic proliferative diseases. On the basis of the general proliferation of bone marrow cells, one or more lines of cells are particularly prominent, which is characterized by continuous hyperproliferation and an increase in the number of mature cells in peripheral blood. The clinical manifestations are heterogeneous, but almost all subtypes are accompanied by an increase in white blood cells, platelets, and megakaryocytes. Myelofibrosis and bone marrow failure appear in the later stage, and some of them can be transformed into other diseases as the disease progresses. Its classic classification is mainly divided into chronic myelogenous leukemia (chronic myelogenous leukemia, CML), polycythemia vera (polycythemia vera, PV), essential thrombocythemia (essential Thrombocythemia, ET) and primary myelofibrosis (primary myelofibrosis) myelofibrosis, PMF), etc.
JAK2基因V617F多态性位点发生在65%~97%的真性红细胞增多症(PV)、23%~57%的原发性血小板增多症(ET)及35%~57%的原发性骨髓纤维化(PMF)患者中。根据JAK2突变与骨髓增生性疾病的密切关系,在修订的2008世界卫生组织(WHO)分类系统中,JAK2基因V617F多态性位点成为慢性骨髓增殖性疾病(MPD)主要的诊断指标。The V617F polymorphism of the JAK2 gene occurs in 65% to 97% of polycythemia vera (PV), 23% to 57% of essential thrombocythemia (ET) and 35% to 57% of primary bone marrow in patients with fibrosis (PMF). According to the close relationship between JAK2 mutation and myeloproliferative diseases, in the revised 2008 World Health Organization (WHO) classification system, the V617F polymorphism of JAK2 gene has become the main diagnostic indicator for chronic myeloproliferative diseases (MPD).
目前对基因突变和基因多态性的检测,常见有直接测序法;基因芯片杂交法;PCR-RFLP方法;PCR扩增产物毛细管电泳分析法;PCR-SSCP;PCR高分辨熔解曲线分析技术;PCR-Taqman MGB(Minor Groove Binder)探针法;AS-PCR法;Cast-PCR法等。这些方法或多或少还存在仪器价格高,操作难度大,存在一定假阴性和假阳性,检测成本高,临床普及程度低,不能同时大规模检测临床标本等缺点。At present, the detection of gene mutation and gene polymorphism commonly includes direct sequencing method; gene chip hybridization method; PCR-RFLP method; PCR amplification product capillary electrophoresis analysis method; PCR-SSCP; PCR high-resolution melting curve analysis technology; PCR -Taqman MGB (Minor Groove Binder) probe method; AS-PCR method; Cast-PCR method, etc. These methods still have more or less shortcomings such as high instrument price, difficult operation, certain false negatives and false positives, high detection cost, low clinical popularity, and inability to simultaneously detect large-scale clinical specimens.
如:1)直接测序法是突变分析的金标准,能发现已知和未知突变位点,但该法检测基因突变的灵敏度为20%(即目的基因的突变基因DNA模板数占野生型DNA模板数的20%)。同时还存在操作复杂,周期长,分析速度慢,常需要2天的时间,而且该法是开管操作,大大增加污染的可能性,不适合对大规模标本的检测,同时还需要昂贵的仪器,存在在基层不易实施等缺点。For example: 1) The direct sequencing method is the gold standard for mutation analysis, which can detect known and unknown mutation sites, but the sensitivity of this method to detect gene mutations is 20% (that is, the number of mutant gene DNA templates of the target gene accounts for the number of wild-type DNA templates 20% of the number). At the same time, the operation is complicated, the cycle is long, the analysis speed is slow, and it usually takes 2 days, and the method is an open-tube operation, which greatly increases the possibility of contamination. It is not suitable for the detection of large-scale samples, and it also requires expensive instruments. , there are shortcomings such as difficult implementation at the grassroots level.
2)普通PCR-RFLP方法技术简便,价格便宜,适宜少量样本的实验室检测,但RFLP仅能检测有酶切位点的突变,无酶切位点不能检测,费时费力,还存在PCR产物污染导致假阳性的风险,见[Mol Diagn Ther. 2010 Jun 1;14(3):163-9, United States Patent20120135406]。2) The common PCR-RFLP method is simple and cheap, and is suitable for laboratory testing of a small number of samples. However, RFLP can only detect mutations with enzyme cleavage sites, and cannot be detected without enzyme cleavage sites. It is time-consuming and laborious, and there is PCR product contamination Risk of causing false positives, see [Mol Diagn Ther. 2010 Jun 1;14(3):163-9, United States Patent20120135406].
3)芯片技术与传统的仪器检测方法相比具有高通量、微型化、自动化等特点,适用于全基因组突变扫描,不适宜单个基因的突变位点检测,且精度低,价格昂贵。3) Compared with traditional instrument detection methods, chip technology has the characteristics of high throughput, miniaturization, and automation. It is suitable for whole-genome mutation scanning, but not suitable for single gene mutation site detection, and its accuracy is low and expensive.
4)PCR高分辨熔解曲线分析技术,能高通量检测基因的突变情况,试剂成本较低,但因其荧光信号来自染料,特异性受到影响,而且检测仪器是升级版的荧光PCR仪,价格高昂,普及受限,见[Clin Chim ACta. 2012 Nov 12;413(21-22):1781-5; United StatesPatent 20110045479]。4) PCR high-resolution melting curve analysis technology can detect gene mutations in high throughput, and the reagent cost is low, but because the fluorescent signal comes from the dye, the specificity is affected, and the detection instrument is an upgraded version of the fluorescent PCR instrument. Expensive, limited access, see [Clin Chim ACta. 2012 Nov 12;413(21-22):1781-5; United States Patent 20110045479].
5)PCR-Taqman MGB探针法适合已知突变位点,常常需要两条探针,而Taqman MGB探针的合成价格是普通Taqman探针的几倍,见 [J Clin Microbiol. 2010 Aug;48(8):2909-15;United States Patent 20090311679],并且不能检测样本中的含量较少(≥1,000个中的1个)的等位基因或突变位点。5) The PCR-Taqman MGB probe method is suitable for known mutation sites, and often requires two probes, and the synthesis price of Taqman MGB probes is several times that of ordinary Taqman probes, see [J Clin Microbiol. 2010 Aug;48 (8):2909-15; United States Patent 20090311679], and cannot detect alleles or mutation sites with a small amount (≥ 1 in 1,000) in the sample.
6)PCR-SSCP法虽然简单,但该法是开放性的检测系统,容易造成PCR产物的污染,而且操作步骤多,费时费力。6) Although the PCR-SSCP method is simple, it is an open detection system, which is easy to cause contamination of PCR products, and there are many operating steps, which are time-consuming and labor-intensive.
7)等位基因特异性引物PCR扩增法(AS-PCR),这一方法是目前检测基因突变或多态性最简单快速的方法(Wu D Y, Ugozzoli L, Pal B K, Wallace R B., Proc NatlAcad Sci USA 1989; 86:2757-2760),其原理是引物3'末端碱基与模板的碱基错配,其PCR的效率将会下降103-106.6倍 (Chen, X., and Sullivan, P F, The PharmacogeonomicsJournal 2003, 3, 77-96)。尽管该方法的原理简单,但错配的引物,依然会发生非特异性扩增,扩增情况视突变的类型和检测位点周围的碱基序列相关(Ayyadevara S, Thaden JJ, Shmookler Reis R J., Anal Biochem 2000; 284:11-18),还与样本中存在的等位基因变量的影响。为了增加AS-PCR的特异性,许多科学家做了很多努力。大量的实验证明,该方法最关键的是设计与3'末端突变位点碱基互补或错配的两条特异引物,引物设计不好,将导致高背景的交叉扩增,会导致较高的假阳性。尽管不少人努力将这一弊端克服,如报道的TaqMAMA方法,在3’倒数第二位或第三位上引入突变碱基,的确可以增加反应的特异性,但仍然无法完全消除假阳性,而且在纯合子与杂合子的判断上,缺乏标准,会出现混乱的情况,见[J Virol Methods. 2008 Nov;153(2):156-62;Genomics. 2004 Feb;83(2):311-20]。简单的AS-PCR,通常采用PCR反应结束后再进行电泳,从有无反应条带来判断结果,这种方法虽然不需要昂贵的仪器,但电泳操作,增加了PCR的污染机会,而且耗时费力。尽管有人对该方法作了改进,采用荧光定量PCR技术,但得到的不是“全或无”式的结果,总会有非特异性反应的发生,即同样的引物对野生型和突变型位点都会扩增,只是其得到的Ct(Cycle threshold)不同而已,因此就引入了ΔCt的概念,即ΔCt=野生Ct- 突变Ct,但计算复杂,如要ΔCt值大于纯合子Ct值判为突变型纯合子,ΔCt值小于杂合子Ct值,判为杂合子,ΔCt值的引入不仅增加了操作步骤,还会引起混乱,因为ΔCt值的设定标准无法准确定位,不同人员的操作、不同的标本和不同的检测仪器都会有不同的数字,给临床应用带来很大的困难,实际应用依然受限,见[中国专利CN101235415,CN101565742A]。7) Allele-specific primer PCR amplification method (AS-PCR), this method is currently the simplest and fastest method for detecting gene mutations or polymorphisms (Wu DY, Ugozzoli L, Pal BK, Wallace R B., Proc NatlAcad Sci USA 1989; 86:2757-2760), its principle is the base mismatch between primer 3' terminal base and template, and the efficiency of its PCR will drop by 10 3 -10 6.6 times (Chen, X., and Sullivan, PF, The Pharmacogeonomics Journal 2003, 3, 77-96). Although the principle of this method is simple, non-specific amplification will still occur with mismatched primers, and the amplification depends on the type of mutation and the base sequence around the detection site (Ayyadevara S, Thaden JJ, Shmookler Reis R J. , Anal Biochem 2000; 284:11-18), also with the influence of allelic variables present in the sample. In order to increase the specificity of AS-PCR, many scientists have made great efforts. A large number of experiments have proved that the key to this method is to design two specific primers that are complementary or mismatched to the bases of the 3' terminal mutation site. If the primer design is not good, it will lead to high background cross-amplification, which will lead to higher false positive. Although many people have worked hard to overcome this disadvantage, such as the reported TaqMAMA method, introducing a mutant base at the penultimate or third position of the 3' can indeed increase the specificity of the reaction, but it still cannot completely eliminate false positives. Moreover, there is a lack of standards in the judgment of homozygotes and heterozygotes, and confusion will occur, see [J Virol Methods. 2008 Nov;153(2):156-62;Genomics. 2004 Feb;83(2):311- 20]. For simple AS-PCR, electrophoresis is usually performed after the PCR reaction is completed, and the result is judged from the presence or absence of reaction bands. Although this method does not require expensive instruments, the electrophoresis operation increases the chance of PCR contamination and is time-consuming. strenuous. Although some people have improved this method by using fluorescent quantitative PCR technology, the results obtained are not "all or nothing", and there will always be non-specific reactions, that is, the same primers will affect both wild-type and mutant sites. Amplification, but the obtained Ct (Cycle threshold) is different, so the concept of ΔCt is introduced, that is, ΔCt=wild Ct-mutant Ct, but the calculation is complicated. Zygote, whose ΔCt value is less than the heterozygous Ct value, is judged as heterozygous. The introduction of the ΔCt value not only increases the operation steps, but also causes confusion, because the setting standard of the ΔCt value cannot be accurately located, and the operation of different personnel, different specimens and Different detection instruments will have different numbers, which brings great difficulties to clinical application, and practical application is still limited, see [Chinese patent CN101235415, CN101565742A].
8)美国LIFE公司采用一种MGB封闭探针的方法,称作Cast-PCR( Competitiveallele specific Taqman PCR),用MGB探针将不检测的位点封闭,然后用等位基因特异引物荧光定量PCR的方法检测目的位点,这虽然提高了检测的特异性,但由于多加入一条MGB封闭探针,势必增加成本,对反应效率多少会带来干扰,见[Exp Mol Pathol. 2012 Jun;92(3):275-80; United States Patent 20100221717;CN102428190A]。有人采用锁核酸(LNA)( Plant Method 2007,3:2)或修饰的碱基(Anal Biochem.2005,340:287-294)的PCR引物,可以使得AS-PCR检测灵敏度提高。然而,这些方法增加了分析的总体成本,并需对反应进行深度优化。8) American LIFE Company adopts a method of MGB blocking probes, called Cast-PCR (Competitiveallele specific Taqman PCR), using MGB probes to block the undetected sites, and then using allele-specific primers for fluorescent quantitative PCR method to detect the target site, although this improves the specificity of detection, but due to the addition of an MGB blocking probe, it is bound to increase the cost and interfere with the reaction efficiency to some extent. See [Exp Mol Pathol. 2012 Jun;92(3 ):275-80; United States Patent 20100221717; CN102428190A]. Some people use PCR primers of locked nucleic acid (LNA) (Plant Method 2007, 3:2) or modified bases (Anal Biochem. 2005, 340: 287-294), which can improve the detection sensitivity of AS-PCR. However, these methods increase the overall cost of the analysis and require deep optimization of the reaction.
因此,如何对JAK2基因V617F多态性位点进行简单准确的检测,成为人们亟待解决的问题。Therefore, how to simply and accurately detect the V617F polymorphism of the JAK2 gene has become an urgent problem to be solved.
发明内容Contents of the invention
鉴于此,本发明提供了一种检测JAK2基因V617F多态性位点的引物、试剂盒及其PCR方法,以至少解决以往试剂盒存在的结果判读复杂、检测仪器价格高,操作难度大,存在一定假阴性和假阳性,检测成本高,临床普及程度低,不能同时大规模检测临床标本等一个或多个问题。In view of this, the present invention provides a primer for detecting the V617F polymorphism site of the JAK2 gene, a kit and a PCR method thereof, to at least solve the complex interpretation of results, high price of detection instruments, difficult operation, and the existence of existing kits in the past. There must be one or more problems such as false negatives and false positives, high testing costs, low clinical popularity, and the inability to simultaneously test large-scale clinical specimens.
本发明提供的方案具体为:一种检测JAK2基因V617F多态性位点的引物,其特征在于,所述引物包括:野生型特异性上游引物、突变型特异性上游引物和野生型特异性上游引物与突变型特异性上游引物共用的下游引物;The solution provided by the present invention is specifically: a primer for detecting the V617F polymorphism site of the JAK2 gene, characterized in that the primers include: wild-type specific upstream primers, mutant-type specific upstream primers and wild-type specific upstream primers. A downstream primer shared by the primer with the mutant-specific upstream primer;
且所述野生型特异性上游引物具有SEQ No.17序列,所述突变型特异性上游引物具有SEQ No.14序列,所述共用的下游引物具有SEQ No.16序列。And the wild-type specific upstream primer has the sequence of SEQ No.17, the mutant-type specific upstream primer has the sequence of SEQ No.14, and the common downstream primer has the sequence of SEQ No.16.
本发明一方面还提供了一种检测JAK2基因V617F多态性位点的试剂,其特征在于:所述试剂含有上述的引物。On the one hand, the present invention also provides a reagent for detecting the V617F polymorphism site of JAK2 gene, characterized in that the reagent contains the above-mentioned primers.
本发明另一方面还提供了一种检测JAK2基因V617F多态性位点的试剂盒,其特征在于:所述试剂盒也含有上述的引物。Another aspect of the present invention also provides a kit for detecting the V617F polymorphic site of the JAK2 gene, which is characterized in that the kit also contains the above-mentioned primers.
优选,所述试剂盒中还包括与所述引物配合使用的探针,其中,所述探针为Taqman探针,具有SEQ No.15序列。Preferably, the kit also includes a probe used in conjunction with the primer, wherein the probe is a Taqman probe with the sequence of SEQ No.15.
进一步优选,所述试剂盒还包括PCR反应管、dNTPs和Taq酶混合液、PCR缓冲液、检测管家基因GAPDH的上游引物、检测管家基因GAPDH的下游引物、检测管家基因GAPDH的探针、阳性质控品和空白对照;Further preferably, the kit also includes PCR reaction tubes, dNTPs and Taq enzyme mixture, PCR buffer, upstream primers for detecting the housekeeping gene GAPDH, downstream primers for detecting the housekeeping gene GAPDH, probes for detecting the housekeeping gene GAPDH, positive Control product and blank control;
所述检测管家基因GAPDH的上游引物具有SEQ No.19序列;所述检测管家基因GAPDH的下游引物具有SEQ No.20序列;所述检测管家基因GAPDH的探针具有SEQ No.21序列。The upstream primer for detecting the housekeeping gene GAPDH has the sequence of SEQ No.19; the downstream primer for detecting the housekeeping gene GAPDH has the sequence of SEQ No.20; and the probe for detecting the housekeeping gene GAPDH has the sequence of SEQ No.21.
进一步优选,所述突变型特异性上游引物、所述共用的下游引物、所述探针、所述检测管家基因GAPDH的上游引物、所述检测管家基因GAPDH的下游引物和所述检测管家基因GAPDH的探针被预先包被于T型PCR反应管内;以及与所述野生型特异性上游引物、所述共用的下游引物、所述探针、所述检测管家基因GAPDH的上游引物、所述检测管家基因GAPDH的下游引物和所述检测管家基因GAPDH的探针被预先包被于G型PCR反应管内。Further preferably, the mutant-specific upstream primer, the shared downstream primer, the probe, the upstream primer for detecting the housekeeping gene GAPDH, the downstream primer for detecting the housekeeping gene GAPDH, and the detection housekeeping gene GAPDH The probe is pre-coated in the T-type PCR reaction tube; and with the wild-type specific upstream primer, the shared downstream primer, the probe, the detection housekeeping gene GAPDH upstream primer, the detection The downstream primers of the housekeeping gene GAPDH and the probe for detecting the housekeeping gene GAPDH are pre-coated in the G-type PCR reaction tube.
进一步优选,所述T型PCR反应管内突变型特异性上游引物、所述共用的下游引物、所述探针、所述检测管家基因GAPDH的上游引物、所述检测管家基因GAPDH的下游引物和所述检测管家基因GAPDH的探针浓度分别为50nM-2um、50nM-2uM、50nM-400nM、1pm-20pm、1pm-20pm、0.05pm-5pm;以及所述G型PCR反应管内野生型特异性上游引物、所述共用的下游引物、所述探针、所述检测管家基因GAPDH的上游引物、所述检测管家基因GAPDH的下游引物和所述检测管家基因GAPDH的探针浓度分别为50nM-2um、50nM-2uM、 50nM-400nM、1pm-20pm、1pm-20pm、0.05pm-5pm。Further preferably, the mutant-specific upstream primer in the T-type PCR reaction tube, the shared downstream primer, the probe, the upstream primer for detecting the housekeeping gene GAPDH, the downstream primer for detecting the housekeeping gene GAPDH, and the The probe concentrations for detecting the housekeeping gene GAPDH are respectively 50nM-2um, 50nM-2uM, 50nM-400nM, 1pm-20pm, 1pm-20pm, 0.05pm-5pm; and the wild-type specific upstream primers in the G-type PCR reaction tube , the shared downstream primer, the probe, the upstream primer for detecting the housekeeping gene GAPDH, the downstream primer for detecting the housekeeping gene GAPDH and the probe concentration for detecting the housekeeping gene GAPDH are respectively 50nM-2um, 50nM -2uM, 50nM-400nM, 1pm-20pm, 1pm-20pm, 0.05pm-5pm.
更进一步优选,所述T型PCR反应管内突变型特异性上游引物、所述共用的下游引物、所述探针、所述检测管家基因GAPDH的上游引物、所述检测管家基因GAPDH的下游引物和所述检测管家基因GAPDH的探针浓度分别为500nM、500nM、100nM、5pm、5pm、2.5pm;以及所述G型PCR反应管内野生型特异性上游引物、所述共用的下游引物、所述探针、所述检测管家基因GAPDH的上游引物、所述检测管家基因GAPDH的下游引物和所述检测管家基因GAPDH的探针浓度分别为500nM、500nM、100nM、5pm、5pm、2.5pm。More preferably, the mutant-specific upstream primers in the T-shaped PCR reaction tube, the shared downstream primers, the probes, the upstream primers for detecting the housekeeping gene GAPDH, the downstream primers for detecting the housekeeping gene GAPDH, and The probe concentrations for detecting the housekeeping gene GAPDH are respectively 500nM, 500nM, 100nM, 5pm, 5pm, and 2.5pm; and the wild-type specific upstream primers in the G-type PCR reaction tube, the shared downstream primers, the probe The concentrations of the needle, the upstream primer for detecting the housekeeping gene GAPDH, the downstream primer for detecting the housekeeping gene GAPDH, and the probe for detecting the housekeeping gene GAPDH were 500nM, 500nM, 100nM, 5pm, 5pm, and 2.5pm, respectively.
本发明还提供了上述引物或试剂盒的PCR方法,其特征在于:PCR反应按两步扩增循环程序进行,且第一步扩增的循环数小于第二步扩增的循环数,所述第一步扩增的退火温度高于所述第二步扩增的退火温度。The present invention also provides the PCR method of the above-mentioned primers or kits, characterized in that: the PCR reaction is carried out according to a two-step amplification cycle program, and the number of cycles of amplification in the first step is less than the number of cycles in the second step of amplification. The annealing temperature of the first step amplification is higher than the annealing temperature of the second step amplification.
优选,所述PCR反应的条件为:37℃2min,95℃ 2min 预变性;第一步扩增,95℃变性 5s,55℃~68℃退火 32s,循环10~15次;第二步,95℃变性 5s,50℃~65℃退火、延伸32s,循环30~50次,收集荧光信号;进一步优选,所述PCR反应的条件为:37℃2min,95℃2min 预变性;第一步扩增,95℃变性 5s,63℃退火 32s,循环15次;第二步,95℃变性 5s,60℃退火、延伸 32s,循环40次,收集荧光信号。Preferably, the conditions of the PCR reaction are: 37°C for 2min, 95°C for 2min for pre-denaturation; first step amplification, 95°C denaturation for 5s, 55°C~68°C annealing for 32s, cycle 10~15 times; second step, 95°C Denaturation at ℃ for 5s, annealing at 50℃~65℃, extension for 32s, cycle 30~50 times, and collect fluorescence signals; further preferably, the conditions of the PCR reaction are: 37℃ for 2 minutes, 95℃ for 2 minutes for pre-denaturation; the first step of amplification , denaturation at 95°C for 5s, annealing at 63°C for 32s, cycle 15 times; the second step, denaturation at 95°C for 5s, annealing at 60°C, extension for 32s, cycle 40 times, and collect fluorescence signals.
本发明提供的检测JAK2基因V617F多态性位点的引物及其试剂盒,能够大大增加等位基因特异性引物PCR区分不同等位基因位点的能力,使不同位点间的非特异性交叉扩增的可能性降到最低,能够做到真正“全或无”式的扩增,不仅有很好的特异性,也具有非常好的灵敏度,能检出1ng基因组DNA中的基因型分布情况。The primers and kits for detecting the V617F polymorphic site of the JAK2 gene provided by the present invention can greatly increase the ability of allele-specific primer PCR to distinguish different allele sites, and make non-specific cross-amplification between different sites possible. The possibility of amplification is minimized, and it can achieve true "all or nothing" amplification. It not only has good specificity, but also has very good sensitivity, and can detect the genotype distribution in 1ng of genomic DNA.
本发明提供的检测JAK2基因V617F多态性位点的引物及其试剂盒,具有以下优点:The primers and kits thereof for detecting the V617F polymorphism site of the JAK2 gene provided by the present invention have the following advantages:
1)通过对引物序列上的人为改变使检测结果真正做到对结果“全或无”判断,大大简化了结果判读的难度,降低了出错的可能,为科研和临床应用提供了无可比拟的便利。1) By artificially changing the primer sequence, the test result can truly achieve an "all or nothing" judgment on the result, which greatly simplifies the difficulty of result interpretation, reduces the possibility of error, and provides unparalleled scientific research and clinical application. convenient.
2)Taq酶与dNTPs的混合,保障了dNTPs的稳定性,使其可经受多次反复冻融的考验。2) The mixture of Taq enzyme and dNTPs ensures the stability of dNTPs, so that it can withstand the test of repeated freezing and thawing.
3)提前预配好可直接使用的缓冲液,使用者更加方便。3) The buffer solution that can be used directly is pre-prepared in advance, which is more convenient for users.
4)引物和探针提前包被在PCR反应管内,避免了操作者出现位点配错的可能,而且也节约了大量操作时间。4) The primers and probes are coated in the PCR reaction tube in advance, which avoids the possibility of site mismatch by the operator and saves a lot of operation time.
5)本发明中引物和试剂盒具有特异性好,检测的灵敏度高,检测速度快,整个过程能在1小时20分钟内完成。5) The primers and kits of the present invention have good specificity, high detection sensitivity and fast detection speed, and the whole process can be completed within 1 hour and 20 minutes.
6)试剂盒内仅用一条常规Taqman探针,别无其他诸如封闭探针,降低成本。6) Only one conventional Taqman probe is used in the kit, and there are no other such as blocking probes to reduce costs.
7)该试剂盒具有检测简单、快速、准确、价廉等优点。7) The kit has the advantages of simple, fast, accurate and cheap detection.
附图说明Description of drawings
图1为设计野生型和突变型引物时的PCR扩增曲线图;Fig. 1 is the PCR amplification curve diagram when designing wild-type and mutant primers;
图2为检测野生型基因序列的PCR扩增曲线图;Fig. 2 is the PCR amplification curve chart of detection wild-type gene sequence;
图3为检测突变型基因序列的PCR扩增曲线图;Fig. 3 is the PCR amplification curve chart of detection mutant gene sequence;
图4为TG位点的PCR扩增曲线图;Fig. 4 is the PCR amplification graph of TG site;
图5为管家基因GAPDH的PCR扩增曲线图。Figure 5 is a PCR amplification curve of the housekeeping gene GAPDH.
具体实施方式Detailed ways
下面以具体的案例对本发明进行进一步解释,但并不用于限制本发明的保护范围。The present invention will be further explained with specific cases below, but it is not intended to limit the protection scope of the present invention.
若未特别指明,实施例中所用的技术手段为本领域技术人员所熟知的常规手段,所用产品均为市购。Unless otherwise specified, the technical means used in the examples are conventional means well known to those skilled in the art, and all products used are commercially available.
以下定义是本发明中相关术语的解释:The following definitions are explanations of relevant terms in the present invention:
“等位基因”一般是指DNA区段,同源染色体上的相同物理位置上,控制相对性状的一对基因。在一些情况下,等位基因可以对应于特定物理基因座上的单核苷酸的替换。在其它情况中,等位基因可以对应于核苷酸(单个或多个)插入或缺失。"Allele" generally refers to a segment of DNA, a pair of genes that control relative traits at the same physical location on homologous chromosomes. In some cases, an allele may correspond to a single nucleotide substitution at a particular physical locus. In other cases, alleles may correspond to insertions or deletions of nucleotides (single or multiple).
“等位基因特异性引物”是指与目标等位基因的序列互补,在PCR时能够延伸完成特异的PCR反应。等位基因特异性引物可以设计成能检测出靶序列中少至1个核苷酸差异十分特异的引物,该引物可以包含等位基因特异性核苷酸部分、3’端靶标特异性部分和尾巴。"Allele-specific primer" means that it is complementary to the sequence of the target allele and can be extended to complete a specific PCR reaction during PCR. Allele-specific primers can be designed to detect as little as 1 nucleotide difference in the target sequence. Very specific primers can contain an allele-specific nucleotide moiety, a 3' target-specific moiety, and Tail.
“MGB基团”是指小沟结合剂。当与寡核苷酸的3’末端缀合时,MGB基团能够作为不可延伸的封闭部分发挥作用。MGB是能结合于双链DNA的小沟内的分子,通常采用DPI3(其合成方法参见美国专利号6,084,102;和6,727,356)。"MGB group" refers to a minor groove binder. When conjugated to the 3' end of an oligonucleotide, the MGB group can function as a non-extensible blocking moiety. MGBs are molecules capable of binding in the minor groove of double-stranded DNA, usually using DPI3 (see US Pat. Nos. 6,084,102; and 6,727,356 for methods of synthesis).
“检测探针”是指:指示扩增的多种信号传导分子中的任意一种。例如,SYBR Green和其它DNA结合染料都是检测探针。一些检测探针可以是序列特异性的,例如Taqman探针(美国专利号5,538,848),多种茎环分子信标(美国专利号6,103,476和5,925,517以及Tyagi and Kramer,Nature Biotechnology,1996,14:303-308),无茎的或线性信标(WO99/21881),PNA Molecular Beacons TM(美国专利号6,355,421和6,593,091),线性PNA信标(Kubista等人,2001,SPIE4264:53-58),非-FRET探针(美国专利号6,150,097),Sunrise/Amplifluor探针(美国专利号6,548,250),茎环和双链Scorpion TM探针(Solinas等人,2001,NucleicAcidsResearch29:E96和美国专利号6,589,743),鼓起的环探针(美国专利号6,590,091),假结探针(美国专利号6,589,250),cyclicon(美国专利号6,383,752),MGBEclipse TM探针(Epoch Biosciences),发夹探针(美国专利号6,596,490),肽核酸(PNA)探针。检测探针可以包含荧光报告分子,例如,6-羧基荧光素(6-FAM)或四氯荧光素(TET),和淬灭分子部分,例如四甲基若丹明(TAMRA),Black Hole Quenche RS(Biosearch),IowaBlack(IDT),QSY猝灭剂(Molecular Probes)和Dabsyl和Dabcel磺酸盐/羧酸盐猝灭剂(Epoch)。"Detection probe"refers to: any of a variety of signaling molecules that indicate amplification. For example, SYBR Green and other DNA-binding dyes are detection probes. Some detection probes can be sequence-specific, such as Taqman probes (US Patent No. 5,538,848), various stem-loop molecular beacons (US Patent Nos. 6,103,476 and 5,925,517 and Tyagi and Kramer, Nature Biotechnology, 1996, 14:303- 308), stemless or linear beacons (WO99/21881), PNA Molecular Beacons™ (US Pat. Nos. 6,355,421 and 6,593,091), linear PNA beacons (Kubista et al., 2001, SPIE4264:53-58), non-FRET Probe (US Patent No. 6,150,097), Sunrise/Amplifluor probe (US Patent No. 6,548,250), stem-loop and double-stranded Scorpion TM probe (Solinas et al., 2001, Nucleic Acids Research 29: E96 and US Patent No. 6,589,743), bulged Circular probe (US Patent No. 6,590,091), pseudoknot probe (US Patent No. 6,589,250), cyclicon (US Patent No. 6,383,752), MGBEclipse TM probe (Epoch Biosciences), hairpin probe (US Patent No. 6,596,490), peptide Nucleic acid (PNA) probes. The detection probe can comprise a fluorescent reporter molecule, for example, 6-carboxyfluorescein (6-FAM) or tetrachlorofluorescein (TET), and a quencher moiety, such as tetramethylrhodamine (TAMRA), Black Hole Quenche RS (Biosearch), IowaBlack (IDT), QSY quencher (Molecular Probes) and Dabsyl and Dabcel sulfonate/carboxylate quenchers (Epoch).
“共用特异性引物”是指在PCR反应中与等位基因特异性引物配对的引物,它能同不同位点的等位基因特异性引物配对使用。"Common-specific primer" refers to a primer paired with an allele-specific primer in a PCR reaction, which can be paired with an allele-specific primer at a different locus.
“热稳定性的聚合酶”是指对热稳定性的或热抗性的酶,主要指DNA聚合酶,该酶在PCR扩增时,在升高的温度条件下不会发生失活。"Thermostable polymerase" refers to thermostable or heat-resistant enzymes, mainly DNA polymerases, which will not be inactivated under elevated temperature conditions during PCR amplification.
寡核苷酸的“Tm”或“熔解温度”是指一段DNA中50%的分子与互补序列杂交时的温度。Tm值可以使用熟知的公式来计算(见,Maniatis,T.等人:Molecular cloning,ColdSpring Harbor,N.Y.:1982)。The "Tm" or "melting temperature" of an oligonucleotide refers to the temperature at which 50% of the molecules in a stretch of DNA hybridize to a complementary sequence. Tm values can be calculated using well-known formulas (see, Maniatis, T. et al.: Molecular cloning, Cold Spring Harbor, N.Y.: 1982).
“灵敏性”是指能够被检出模板的最小量(拷贝数)。"Sensitivity" refers to the minimum amount (copy number) of a template that can be detected.
“特异性”是指区分匹配模板和错配模板的能力。特异性经常表示为ΔCt=Ct错配-Ct匹配。"Specificity" refers to the ability to distinguish a matched template from a mismatched template. Specificity is often expressed as ΔCt = Ct mismatch - Ct match.
“选择性”是指AS-PCR测定可用于测定混合物中的少数(通常是突变)等位基因而无来自多数(经常是野生型)等位基因的干扰的程度。选择性经常表示为比例或百分率。例如,能够在存在100个野生型模板的情况下检出1个突变模板的测定被称作具有1∶100或1%的选择性。"Selectivity" refers to the degree to which an AS-PCR assay can be used to detect the minority (usually mutant) allele in a mixture without interference from the majority (often wild-type) allele. Selectivity is often expressed as a ratio or percentage. For example, an assay capable of detecting 1 mutant template in the presence of 100 wild-type templates is said to have a selectivity of 1:100 or 1%.
“Ct”值是指循环阈值,代表PCR扩增曲线由基线变为指数增长拐点时的循环数。The "Ct" value refers to the cycle threshold, which represents the cycle number when the PCR amplification curve changes from the baseline to the inflection point of exponential growth.
“德尔塔Ct”或“ΔCt”是指信号通过固定阈值时,两个不同样品或反应之间的循环数差异。ΔCt是达到指数扩增时,两个不同样品或反应之间的循环数差异。ΔCt可用于鉴定匹配引物与错配引物之间的特异性。"Delta Ct" or "ΔCt" is the difference in cycle number between two different samples or reactions when the signal crosses a fixed threshold. ΔCt is the difference in cycle number between two different samples or reactions at which exponential amplification is achieved. ΔCt can be used to identify specificity between matched and mismatched primers.
本发明涉及快速检测JAK2基因的V617F突变位点的引物和试剂盒。具体地讲,本发明是基于Past-PCR(Perfect allele-specific Taqman PCR)方法的基础上,成功应用于JAK2基因V617F的多态性位点检测。所谓Past-PCR是由检测基因多态性或突变的高特异性AS-PCR方法和Taqman探针的荧光PCR技术结合而成,其仅用一条Taqman探针,在多数的情况下,这条探针为常规的Taqman探针,仅在部分基因中因富含AT碱基的特殊序列,采用Taqman-MGB或LNA等探针,除此之外无需任何额外的封闭探针或报告探针,Past-PCR方法将AS-PCR和Taqman荧光PCR两种方法完美结合,并使两者的优点得到了极度的发挥,具体表现在AS-PCR方法中,在不增加任何成本的情况下,靠引物设计和独特的验证方法成功消除了非特异性扩增,使得结果判断呈现出“全和无”方式,即有就有,没有就没有,使得结果的判断简单而准确,这是对过去的AS-PCR方法最大的改进,也是对AS-PCR方法为人所诟病的有效弥补,从而将AS-PCR方法的优点发挥到了极致,是该方法所能达到的最高境界。众所周知,Taqman荧光PCR具有密闭性检测无需反应完结后的处理,不仅节省了时间,而且减少了PCR产物污染的风险,探针的第二次识别靶序列保障了检测的特异性和可靠性,还可用于对基因的定量检测,达到了临床使用标准等优点。Past-PCR方法具有AS-PCR方法和Taqman荧光PCR方法的双重优点,并且是这两种方法结合在一起时,检测组份所能达到的最简化构成,因此,我们将其称作为完美的等位基因特异性Taqman PCR。The invention relates to a primer and a kit for rapidly detecting the V617F mutation site of the JAK2 gene. Specifically, the present invention is based on the Past-PCR (Perfect allele-specific Taqman PCR) method, and is successfully applied to the detection of the polymorphic site of JAK2 gene V617F. The so-called Past-PCR is a combination of the highly specific AS-PCR method for detecting gene polymorphisms or mutations and the fluorescent PCR technology of Taqman probes. It only uses one Taqman probe. The needle is a conventional Taqman probe, only in some genes due to the special sequence rich in AT bases, using Taqman-MGB or LNA probes, in addition to no additional blocking probes or reporter probes, Past -PCR method perfectly combines AS-PCR and Taqman fluorescent PCR methods, and makes the advantages of the two get extreme play, specifically in the AS-PCR method, without increasing any cost, by primer design And the unique verification method successfully eliminates non-specific amplification, making the result judgment present an "all and nothing" method, that is, if there is, there is no, so that the judgment of the result is simple and accurate, which is an improvement on the past AS-PCR The biggest improvement of the method is also an effective remedy for the criticism of the AS-PCR method, so that the advantages of the AS-PCR method can be brought into full play, which is the highest state that the method can achieve. As we all know, Taqman fluorescent PCR has airtight detection without the need for post-reaction processing, which not only saves time, but also reduces the risk of PCR product contamination. The second recognition target sequence of the probe ensures the specificity and reliability of the detection, and also It can be used for quantitative detection of genes, and has reached the advantages of clinical application standards. The Past-PCR method has the dual advantages of the AS-PCR method and the Taqman fluorescent PCR method, and is the most simplified composition that can be achieved by the detection components when the two methods are combined, so we call it a perfect equivalent. Allele-specific Taqman PCR.
基于Past-PCR方法,发明了用于检测JAK2基因V617F多态性位点的试剂盒,其基本组成为:(a)高度特异的等位基因特异性引物;(b)荧光检测探针;(c)与等位基因特异性引物配对的另一条特异性引物。Based on the Past-PCR method, a kit for detecting the V617F polymorphism site of the JAK2 gene was invented, which basically consists of: (a) highly specific allele-specific primers; (b) fluorescent detection probes; ( c) Another specific primer paired with the allele-specific primer.
其中,本发明提供的检测JAK2基因V617F多态性位点的引物,包括:野生型特异性上游引物、突变型特异性上游引物和野生型特异性上游引物与突变型特异性上游引物共用的下游引物;Wherein, the primers for detecting the V617F polymorphic site of the JAK2 gene provided by the present invention include: a wild-type specific upstream primer, a mutant-specific upstream primer, and a downstream shared by the wild-type specific upstream primer and the mutant-specific upstream primer. Primer;
且所述野生型特异性上游引物具有SEQ No.17序列,所述突变型特异性上游引物具有SEQ No.14序列,所述共用的下游引物具有SEQ No.16序列。And the wild-type specific upstream primer has the sequence of SEQ No.17, the mutant-type specific upstream primer has the sequence of SEQ No.14, and the common downstream primer has the sequence of SEQ No.16.
同时还提供了含有上述引物的检测试剂和试剂盒,以解决以往检测JAK2基因V617F多态性位点存在操作难度大,存在一定假阴性和假阳性,检测成本高,临床普及程度低,不能同时大规模检测临床标本等问题,实现了检测简单、快速、准确、廉价的理想要求,为科研和临床基因型和基因突变分析提供了强有力的工具。At the same time, detection reagents and kits containing the above primers are also provided to solve the difficulties in detecting the V617F polymorphism site of the JAK2 gene in the past, certain false negatives and false positives, high detection costs, and low clinical popularity. Large-scale detection of clinical specimens and other issues has achieved the ideal requirements of simple, fast, accurate, and cheap detection, and provides a powerful tool for scientific research and clinical genotype and gene mutation analysis.
优选,所述试剂盒中还包括与所述引物配合使用的探针,其中,所述探针为Taqman探针,具有SEQ No.15序列,整个试剂盒中仅使用一条探针,别无其他诸如封闭探针等,降低试剂盒的成本。Preferably, the kit also includes a probe used in conjunction with the primer, wherein the probe is a Taqman probe with a sequence of SEQ No.15, and only one probe is used in the entire kit without other Such as blocking probes, etc., reduce the cost of the kit.
进一步优选,所述试剂盒还包括PCR反应管、dNTPs和Taq酶混合液、PCR缓冲液、检测管家基因GAPDH的上游引物、检测管家基因GAPDH的下游引物、检测管家基因GAPDH的探针、阳性质控品和空白对照;Further preferably, the kit also includes PCR reaction tubes, dNTPs and Taq enzyme mixture, PCR buffer, upstream primers for detecting the housekeeping gene GAPDH, downstream primers for detecting the housekeeping gene GAPDH, probes for detecting the housekeeping gene GAPDH, positive Control product and blank control;
所述检测管家基因GAPDH的上游引物具有SEQ No.19序列;所述检测管家基因GAPDH的下游引物具有SEQ No.20序列;所述检测管家基因GAPDH的探针具有SEQ No.21序列;其中,将dNTPs和Taq酶混合,能够保障dNTPs的稳定性,使其可经受多次反复冻融的考验;检测管家基因GAPDH的上游引物、下游引物和探针是用于作为内参照,为防止检测时出现假阴性;阳性质控品为TG型人基因组DNA;空白对照为灭菌超纯水。The upstream primer for detecting the housekeeping gene GAPDH has the sequence of SEQ No.19; the downstream primer for detecting the housekeeping gene GAPDH has the sequence of SEQ No.20; the probe for detecting the housekeeping gene GAPDH has the sequence of SEQ No.21; wherein, Mixing dNTPs and Taq enzymes can ensure the stability of dNTPs so that they can withstand repeated freeze-thaw tests; the upstream primers, downstream primers and probes for detecting the housekeeping gene GAPDH are used as internal references to prevent False negatives occurred; the positive quality control was TG-type human genomic DNA; the blank control was sterilized ultrapure water.
进一步优选,所述突变型特异性上游引物、所述共用的下游引物、所述探针、所述检测管家基因GAPDH的上游引物、所述检测管家基因GAPDH的下游引物和所述检测管家基因GAPDH的探针被预先包被于T型PCR反应管内;以及与所述野生型特异性上游引物、所述共用的下游引物、所述探针、所述检测管家基因GAPDH的上游引物、所述检测管家基因GAPDH的下游引物和所述检测管家基因GAPDH的探针被预先包被于G型PCR反应管内,按最佳的反应用量预先包被在PCR反应管中,每一个反应管中实际包被六条寡核甘酸,即一条针对等位基因的一种特异性上游引物、一条探针(通常为Taqman探针)、一条共用特异性下游引物、一条检测管家基因GAPDH上游引物、一条检测管家基因GAPDH下游引物和一条检测管家基因GAPDH探针。这样为了检测一个位点不同的基因多态性,常需要分别包被两管或两管以上的PCR反应管,它们中探针、共用特异性下游引物、检测管家基因GAPDH的上游引物、下游引物和探针是一样的,不同的仅是鉴定等位基因不同型别的特异性上游引物,这样预先包被避免了操作者出现位点配错的可能,而且节约了大量操作时间。Further preferably, the mutant-specific upstream primer, the shared downstream primer, the probe, the upstream primer for detecting the housekeeping gene GAPDH, the downstream primer for detecting the housekeeping gene GAPDH, and the detection housekeeping gene GAPDH The probe is pre-coated in the T-type PCR reaction tube; and with the wild-type specific upstream primer, the shared downstream primer, the probe, the detection housekeeping gene GAPDH upstream primer, the detection The downstream primers of the housekeeping gene GAPDH and the probes for detecting the housekeeping gene GAPDH are pre-coated in G-type PCR reaction tubes, and are pre-coated in the PCR reaction tubes according to the optimal reaction amount, and each reaction tube is actually coated with Six oligonucleotides, one specific upstream primer for alleles, one probe (usually a Taqman probe), one shared specific downstream primer, one upstream primer for detecting the housekeeping gene GAPDH, one detecting the housekeeping gene GAPDH Downstream primers and a probe to detect the housekeeping gene GAPDH. In this way, in order to detect different gene polymorphisms at one locus, it is often necessary to coat two or more PCR reaction tubes respectively. Among them, the probe, the common specific downstream primer, the upstream primer for detecting the housekeeping gene GAPDH, and the downstream primer It is the same as the probe, and the only difference is the specific upstream primers for identifying different types of alleles. This pre-coating avoids the possibility of site mismatch by the operator and saves a lot of operating time.
进一步优选,所述T型PCR反应管内突变型特异性上游引物、所述共用的下游引物、所述探针、所述检测管家基因GAPDH的上游引物、所述检测管家基因GAPDH的下游引物和所述检测管家基因GAPDH的探针浓度分别为50nM-2um、50nM-2uM、50nM-400nM、1pm-20pm、1pm-20pm、0.05pm-5pm;以及所述G型PCR反应管内野生型特异性上游引物、所述共用的下游引物、所述探针、所述检测管家基因GAPDH的上游引物、所述检测管家基因GAPDH的下游引物和所述检测管家基因GAPDH的探针浓度分别为50nM-2um、50nM-2uM、50nM-400nM、1pm-20pm、1pm-20pm、0.05pm-5pm。最优为,所述T型PCR反应管内突变型特异性上游引物、所述共用的下游引物、所述探针、所述检测管家基因GAPDH的上游引物、所述检测管家基因GAPDH的下游引物和所述检测管家基因GAPDH的探针浓度分别为500nM、500nM、100nM、5pm、5pm、2.5pm;以及所述G型PCR反应管内野生型特异性上游引物、所述共用的下游引物、所述探针、所述检测管家基因GAPDH的上游引物、所述检测管家基因GAPDH的下游引物和所述检测管家基因GAPDH的探针浓度分别为500nM、500nM、100nM、5pm、5pm、2.5pm。Further preferably, the mutant-specific upstream primer in the T-type PCR reaction tube, the shared downstream primer, the probe, the upstream primer for detecting the housekeeping gene GAPDH, the downstream primer for detecting the housekeeping gene GAPDH, and the The probe concentrations for detecting the housekeeping gene GAPDH are respectively 50nM-2um, 50nM-2uM, 50nM-400nM, 1pm-20pm, 1pm-20pm, 0.05pm-5pm; and the wild-type specific upstream primers in the G-type PCR reaction tube , the shared downstream primer, the probe, the upstream primer for detecting the housekeeping gene GAPDH, the downstream primer for detecting the housekeeping gene GAPDH and the probe concentration for detecting the housekeeping gene GAPDH are respectively 50nM-2um, 50nM -2uM, 50nM-400nM, 1pm-20pm, 1pm-20pm, 0.05pm-5pm. Optimally, the mutant-specific upstream primers in the T-type PCR reaction tube, the shared downstream primers, the probe, the upstream primers for detecting the housekeeping gene GAPDH, the downstream primers for detecting the housekeeping gene GAPDH, and The probe concentrations for detecting the housekeeping gene GAPDH are respectively 500nM, 500nM, 100nM, 5pm, 5pm, and 2.5pm; and the wild-type specific upstream primers in the G-type PCR reaction tube, the shared downstream primers, the probe The concentrations of the needle, the upstream primer for detecting the housekeeping gene GAPDH, the downstream primer for detecting the housekeeping gene GAPDH, and the probe for detecting the housekeeping gene GAPDH were 500nM, 500nM, 100nM, 5pm, 5pm, and 2.5pm, respectively.
由于在等位基因特异性引物内引入了错配的碱基,使其在反应时的效率下降,不同的引物下降程度不同,通常要增加10至20个循环才能达到没有错配时的效果,保证检测的灵敏度,优选PCR反应按两步扩增循环程序进行,且第一步扩增的循环数小于第二步扩增的循环数,所述第一步扩增的退火温度高于第二步扩增的退火温度,第一步扩增使用较高退火温度,第二步扩增使用较低退火温度,目的是增加第一步扩增时引物退火时的特异性,从而保证Past-PCR检测高度特异性的目的;具体而言优选所述PCR反应的条件为:37℃2min,95℃ 2min 预变性;第一步扩增,95℃变性 5s,55℃~68℃退火 32s,循环10~15次;第二步,95℃变性 5s,50℃~65℃退火、延伸 32s,循环30~50次,收集荧光信号;更为优选PCR反应的条件为:37℃ 2min,95℃ 2min 预变性;第一步扩增,95℃变性 5s,63℃退火 32s,循环15次;第二步,95℃变性 5s,60℃退火、延伸 32s,循环40次,收集荧光信号。Due to the introduction of mismatched bases in the allele-specific primers, the efficiency of the reaction is reduced, and different primers have different degrees of decline. Usually, it takes 10 to 20 cycles to achieve the effect without mismatches. To ensure the sensitivity of detection, the preferred PCR reaction is carried out by a two-step amplification cycle program, and the number of cycles of the first step amplification is less than the number of cycles of the second step amplification, and the annealing temperature of the first step amplification is higher than that of the second step amplification. The annealing temperature of the first step amplification, the first step amplification uses a higher annealing temperature, and the second step amplification uses a lower annealing temperature, the purpose is to increase the specificity of the primer annealing during the first step amplification, so as to ensure Detect the purpose of high specificity; specifically, the preferred conditions of the PCR reaction are: 37°C for 2 minutes, 95°C for 2 minutes for pre-denaturation; the first step of amplification, 95°C for 5 seconds, 55°C to 68°C for 32 seconds, cycle 10 ~15 times; in the second step, denature at 95°C for 5s, anneal at 50°C~65°C, extend for 32s, cycle 30~50 times, and collect fluorescence signals; the more preferred PCR reaction conditions are: 37°C for 2min, 95°C for 2min Denaturation; the first step of amplification, 95°C denaturation for 5 s, 63°C annealing for 32 s, cycle 15 times; the second step, 95°C denaturation for 5 s, 60°C annealing, extension for 32 s, cycle 40 times, and collect fluorescence signals.
具体的检测过程为:The specific detection process is:
1)将待检测样品分别放入预先分别包被有野生型特异引物、共用的下游引物、探针、检测管家基因GAPDH的上游引物、检测管家基因GAPDH的下游引物和检测管家基因GAPDH的探针以及突变型特异引物、共用的下游引物、探针、检测管家基因GAPDH的上游引物、检测管家基因GAPDH的下游引物和检测管家基因GAPDH的探针的两组PCR反应管内,并加入PCR缓冲液、dNTPs和Taq酶混合液、灭菌超纯水和基因组DNA,盖紧管盖,在荧光定量PCR仪上进行反应,并收集荧光信号;1) Put the samples to be tested into pre-coated wild-type specific primers, shared downstream primers, probes, upstream primers for detecting the housekeeping gene GAPDH, downstream primers for detecting the housekeeping gene GAPDH, and probes for detecting the housekeeping gene GAPDH And two sets of PCR reaction tubes of mutant-type specific primers, shared downstream primers, probes, upstream primers for detecting housekeeping gene GAPDH, downstream primers for detecting housekeeping gene GAPDH and probes for detecting housekeeping gene GAPDH, and add PCR buffer, dNTPs and Taq enzyme mixture, sterilized ultrapure water and genomic DNA, tightly cap the tube, react on a fluorescent quantitative PCR instrument, and collect fluorescent signals;
2)如果检测样本仅有突变型反应管在FAM通道有对数增长的扩增曲线,同时VIC通道有对数增长的扩增曲线,可判定样本为T型,即突变型纯合子;2) If only the mutant reaction tube in the test sample has a logarithmic growth amplification curve in the FAM channel, and the VIC channel has a logarithmic growth amplification curve, it can be determined that the sample is T type, that is, the mutant homozygote;
如果检测样本仅有野生型反应管在FAM通道有对数增长的扩增曲线,同时VIC通道有对数增长的扩增曲线,可判定样本为G型,即野生型纯合子;If only the wild-type reaction tube in the test sample has a logarithmic growth amplification curve in the FAM channel, and the VIC channel has a logarithmic growth amplification curve, it can be determined that the sample is G type, that is, wild-type homozygosity;
如果检测样本突变型和野生型反应管在FAM通道均有对数增长的扩增曲线,同时VIC通道有对数增长的扩增曲线,可判定样本为TG型,即杂合子;If the test sample mutant type and wild type reaction tubes have logarithmic growth amplification curves in the FAM channel, and the VIC channel has a logarithmic growth amplification curve, it can be determined that the sample is TG type, that is, heterozygous;
如果检测样本突变型和野生型反应管在FAM通道均无对数增长的扩增曲线,可能样本或操作存在问题,或者样本DNA浓度过低,应重新提取样本DNA进行试验。If there is no logarithmic growth amplification curve in the FAM channel of the test sample mutant and wild-type reaction tubes, there may be problems with the sample or operation, or the sample DNA concentration is too low, and the sample DNA should be re-extracted for testing.
下面详述检测过程中各组份介绍:The following details the introduction of each component in the detection process:
(一)等位基因特异性引物:(1) Allele-specific primers:
等位基因特异性引物的等位基因特异性核苷酸部分互补于基因的一个等位基因位点,但不互补于该基因的另一个等位基因位点。通常而言,等位基因特异性引物的等位基因特异性核苷酸部分位于等位基因特异性引物的3’端的末位碱基。在某些情况下,等位基因特异性核苷酸部分也可位于等位基因特异性引物3’末端的其他碱基位置。The allele-specific nucleotide portion of an allele-specific primer is complementary to one allelic position of a gene, but not to the other allelic position of the gene. Typically, the allele-specific nucleotide portion of the allele-specific primer is located at the last base of the 3' end of the allele-specific primer. In some cases, the allele-specific nucleotide moiety may also be located at other base positions at the 3' end of the allele-specific primer.
在一些情况下,等位基因特异性引物除3’末端互补于等位基因位点有所变化外,我们常常要在引物的其他位置引入错配的碱基,如在引物3’端倒数第二位或第三位引入碱基错配,或第二和第三位的连续错配;针对不同的多态性或突变位点,在引物3’端倒数第二位或第三位引入碱基错配的基础上,还可在引物的其它位点增加碱基错配来满足反应特异性的要求,越远离3’端,增加错配的碱基数越多,在5’端可达最多。等位基因特异性引物的长度主要依据其Tm值来决定,通常而言其Tm值比PCR循环的退火温度低大约5-20℃。In some cases, except that the 3' end of the allele-specific primer is complementary to the allelic site, we often introduce mismatched bases at other positions of the primer, such as the penultimate base at the 3' end of the primer. Introduce a base mismatch at the second or third position, or a continuous mismatch between the second and third positions; for different polymorphisms or mutation sites, introduce a base at the penultimate or third position at the 3' end of the primer On the basis of base mismatches, base mismatches can also be added at other positions of the primer to meet the requirements of reaction specificity. The farther away from the 3' end, the more bases to increase the number of mismatches. It can be reached at the 5' end. most. The length of the allele - specific primer is mainly determined by its Tm value, which is generally about 5-20°C lower than the annealing temperature of the PCR cycle.
两条检测对应基因多态性的等位基因特异性上游引物,除3’端检测的位点其碱基不同外,其余序列尽可能相同,二条引物的Tm值也尽可能一致。The two allele-specific upstream primers for detecting corresponding gene polymorphisms have the same sequence as possible except for the base detected at the 3' end, and the T m values of the two primers are also as consistent as possible.
低Tm的等位基因特异性引物(ASP)有更高的特异性。一般情况下,等位基因特异性引物为短寡核苷酸,其长度是大约15-30,其Tm是大约40℃至60℃,比扩增过程中使用的PCR循环条件的退火/延伸温度低大约5℃至20℃。Allele-specific primers (ASP) with low T m have higher specificity. In general, allele-specific primers are short oligonucleotides that are approximately 15-30 Å in length and whose Tm is approximately 40°C to 60°C, which is less than the annealing/extension of the PCR cycling conditions used during amplification. The temperature is about 5°C to 20°C lower.
由于等位基因特异性引物的设计和筛选十分重要,好的引物需要从众多待选的引物中选出,因此我们建立了一个筛选的方法,其等位基因特异性引物的具体筛选过程如下:Because the design and screening of allele-specific primers are very important, good primers need to be selected from many primers to be selected, so we have established a screening method, and the specific screening process for allele-specific primers is as follows:
⑴设计外围引物及PCR扩增:首先在待检基因突变点或多态性位点的上下游,设计一对PCR扩增引物,然后用该对引物,对目的基因进行常规的PCR反应,其中扩增片段长度可在几十至数千碱基对,优选长度为200至500碱基对;(1) Design peripheral primers and PCR amplification: first, design a pair of PCR amplification primers upstream and downstream of the mutation point or polymorphic site of the gene to be detected, and then use the pair of primers to perform a conventional PCR reaction on the target gene, wherein The length of the amplified fragment can be tens to thousands of base pairs, preferably 200 to 500 base pairs;
⑵克隆PCR产物:将扩增出的PCR产物,利用AT克隆的方法,重组到普通的T载体质粒中,得到重组质粒,其中得到的重组质粒可以进行测序验证,从而确保PCR产物的正确性;(2) Clone the PCR product: Recombine the amplified PCR product into a common T vector plasmid by AT cloning method to obtain a recombinant plasmid, which can be sequenced and verified to ensure the correctness of the PCR product;
⑶构建重组突变体:根据生物信息学所提供的信息,采用分子克隆技术,将突变体的序列,构建至上述得到的重组质粒中,将构建的重组突变体进行测序验证序列,从而确保其正确性;(3) Construction of recombinant mutants: According to the information provided by bioinformatics, molecular cloning techniques were used to construct the sequence of the mutants into the recombinant plasmids obtained above, and the sequence of the constructed recombinant mutants was sequenced to ensure that they were correct. sex;
⑷设计及筛选突变位点特异性引物:设计两条等位基因特异性引物,一条引物的3’端同突变序列互补,另一条引物的3’端同正常序列互补;然后分别用等位基因特异性引物和对应的常规PCR共同下游引物配对,以上述构建好的重组突变体作为反应模板,利用荧光定量PCR仪,对反应体系,进行筛选;其中,反应可采用荧光染料,如SYBR GREEN,也可采用特异性的Taqman荧光探针,按照所加样品量为0.1微克全基因组DNA的标准进行筛选,其具体的筛选内容如下:(4) Design and screening of mutation site-specific primers: design two allele-specific primers, one primer’s 3’ end is complementary to the mutant sequence, and the other primer’s 3’ end is complementary to the normal sequence; The specific primers are paired with the corresponding conventional PCR common downstream primers, and the recombinant mutant constructed above is used as the reaction template, and the reaction system is screened using a fluorescent quantitative PCR instrument; wherein, the reaction can use fluorescent dyes, such as SYBR GREEN, Specific Taqman fluorescent probes can also be used to screen according to the standard that the added sample volume is 0.1 micrograms of whole-genome DNA, and the specific screening content is as follows:
(a)设定PCR反应条件:首先设定PCR反应的退火温度完全一致,具体温度为55℃~68℃,PCR循环次数为40次,PCR反应的酶和缓冲体系均优化后固定不变,此反应条件的设定是为了方便同时检测多种基因突变;(a) Set the PCR reaction conditions: first set the annealing temperature of the PCR reaction to be exactly the same, the specific temperature is 55 ° C ~ 68 ° C, the number of PCR cycles is 40 times, and the enzyme and buffer system of the PCR reaction are optimized and fixed. The setting of this reaction condition is to facilitate simultaneous detection of multiple gene mutations;
(b)特异性筛选:采用突变型的引物以野生型的重组质粒为模板,筛选出的引物其Ct大于40;(b) Specific screening: Use mutant primers and wild-type recombinant plasmids as templates, and the Ct of the screened primers is greater than 40;
其中循环阈值的确定原因如下,突变型引物在野生型模板发生非特异性扩增比野生型引物在野生型模板发生特异性扩增多19个循环,按照临床实际检测时,所加样品量为0.1微克全基因组DNA的标准,我们通过下列公式,拷贝数=(DNA量ng×6.022×1023)/(长度bp×109×660),其中全基因组DNA的长度为30亿对碱基,因此0.1微克全基因组DNA的拷贝数为:3.09×104,反映在荧光定量PCR的Ct(定量循环阈值)大概为21,这样我们得到第二个筛选指标,即用突变型的引物,在野生型的重组质粒为模板时,所得的Ct应该大于40,方能保证检测不会出现假阳性,两者的扩增效率相差为40-21=19个循环,即扩增效率相差19个循环以上,将成为我们判断等位基因特异性引物特异性好坏的客观指标。我们知道当引物3’端与模板错配时,延伸效率将下降103-106.6倍,换算成反应循环数则下降约13至27个循环,这就是我们能筛选出理想引物的理论依据,因为不进行引物筛选,19-13=6个循环,势必产生假阳性,该引物的特异性就不好,而19-27=-8,不可能产生假阳性,有8个循环数的范围供我们对引物进行筛选。按照这一要求,我们设计一系列等位基因特异性引物,从长短上、从靠近3’端人为引入碱基错配上着手,加上其配对的下游引物,利用构建好的野生型和突变型重组质粒,分别进行荧光定量PCR反应的交叉筛选,即当用突变引物与野生型的模板进行扩增时,与用野生型引物同野生型模板的反应要多用19个循环数以上,反之亦然,那么这样的引物就具备高度的特异性。The reason for determining the cycle threshold is as follows. The non-specific amplification of the mutant primer in the wild-type template is 19 cycles longer than the specific amplification of the wild-type primer in the wild-type template. According to the actual clinical detection, the amount of sample added is 0.1 For the standard of micrograms of whole-genome DNA, we use the following formula, copy number = (DNA amount ng×6.022×10 23 )/(length bp×10 9 ×660), where the length of whole-genome DNA is 3 billion base pairs, so The copy number of 0.1 μg of whole-genome DNA is: 3.09×10 4 , and the Ct (quantitative cycle threshold) reflected in fluorescent quantitative PCR is about 21, so we get the second screening index, that is, using mutant primers, in the wild-type When the recombinant plasmid is used as the template, the obtained Ct should be greater than 40 to ensure that no false positives will occur in the detection. The difference in amplification efficiency between the two is 40-21=19 cycles, that is, the difference in amplification efficiency is more than 19 cycles. It will be an objective indicator for us to judge the specificity of allele-specific primers. We know that when the 3' end of the primer is mismatched with the template, the extension efficiency will decrease by 10 3 -10 6.6 times, and the number of reaction cycles will decrease by about 13 to 27 cycles. This is the theoretical basis for us to screen out ideal primers. Because there is no primer screening, 19-13=6 cycles will inevitably produce false positives, and the specificity of the primer is not good, and 19-27=-8, it is impossible to produce false positives, and there are 8 cycles for the range of numbers. We screen the primers. In accordance with this requirement, we designed a series of allele-specific primers, starting from the length and artificially introducing base mismatches near the 3' end, plus their paired downstream primers, using the constructed wild-type and mutant Recombinant plasmids, carry out the cross-screening of fluorescent quantitative PCR reactions respectively, that is, when using mutant primers and wild-type templates for amplification, it takes more than 19 cycles to react with wild-type primers and wild-type templates, and vice versa Of course, such primers are highly specific.
(c)敏感性筛选:将筛选出的特异性引物用与重组突变型质粒作敏感性试验,将检测灵敏度小于10-1000个拷贝的特异性引物筛选出来,即为所需的突变特异性引物。(c) Sensitivity screening: use the screened specific primers for a sensitivity test with the recombinant mutant plasmid, and screen out specific primers with a detection sensitivity of less than 10-1000 copies, which are the required mutation-specific primers .
通过以上几方面的筛选,所得到的等位基因特异性引物将具备高度特异性和高度敏感的理想引物。Through the screening of the above aspects, the obtained allele-specific primers will be ideal primers with high specificity and high sensitivity.
(二)检测探针:(2) Detection probe:
在一些情况下,检测探针的Tm值大约为60℃至70℃,最佳为65℃,探针长度根据其Tm值决定。尽管有多种不同形式的探针可供选择,Taqman探针(Applied Biosystems,Foster City)常常是首选。在一些特殊的情况下,如检测序列中AT含量过高,可以采用提高Tm值的Taqman-MGB等类型的探针。In some cases, the Tm value of the detection probe is about 60°C to 70°C, preferably 65°C, and the length of the probe is determined according to its Tm value. Although there are many different formats of probes available, Taqman probes (Applied Biosystems, Foster City) are often the first choice. In some special cases, such as the content of AT in the detection sequence is too high, probes such as Taqman-MGB with increased T m value can be used.
共用的特异性引物,在一些情况下,共用的特异性引物的Tm值大约为50℃至70℃,最佳为60℃,其长度由其Tm值决定,一般在15-25碱基之间。Shared specific primers, in some cases, the T m value of shared specific primers is about 50°C to 70°C, the best is 60°C, and its length is determined by its T m value, generally 15-25 bases between.
(三)其他成分:(3) Other ingredients:
本发明使用的DNA聚合酶是Taq酶,及其突变体、衍生物或片段,也可是其他的耐热DNA聚合酶,在一些情况下,也可采用Hotstart Taq酶,以增加反应的特异和高效性。The DNA polymerase that the present invention uses is Taq enzyme, and mutant, derivative or fragment thereof, also can be other thermostable DNA polymerase, in some cases, also can adopt Hotstart Taq enzyme, to increase the specificity and efficient of reaction sex.
本发明中所提供的针对JAK2基因V617F多态性位点所提供的引物和试剂盒,主要是针对等位基因特异性引物PCR扩增法的缺点,利用分子克隆技术,事先分别构建含待检基因野生型和突变型的重组质粒,以此重组质粒为阳性模板,筛选确定特异地分别与3'末端突变位点或野生位点碱基互补的两条特异引物,一旦筛选出的特异引物序列,将是我们检测体系的关键元素。本发明的上述产品,可用于任何型号的荧光定量PCR仪,试剂成本同如今市面上的荧光定量PCR试剂相当,因此较好地克服了其他采用等位基因特异性引物PCR扩增法的不足。The primers and kits provided for the JAK2 gene V617F polymorphic site provided in the present invention are mainly aimed at the shortcomings of the allele-specific primer PCR amplification method. Gene wild-type and mutant-type recombinant plasmids, using the recombinant plasmid as a positive template, screen to determine two specific primers that are complementary to the 3' terminal mutation site or wild site base, once the specific primer sequence is screened , will be a key element of our detection system. The above-mentioned product of the present invention can be used in any type of fluorescent quantitative PCR instrument, and the reagent cost is equivalent to that of fluorescent quantitative PCR reagents on the market today, so it overcomes the shortcomings of other PCR amplification methods using allele-specific primers.
本发明的优点在于:所述的试剂盒具有操作简单,成本低,结果判断简单容易,灵敏度高,本试剂盒检测基因突变灵敏度可以达到1%(即目的基因的突变基因DNA 模板数占野生型DNA模板数的1%);而直接测序中检测基因突变的灵敏度为20%(即目的基因的突变基因DNA 模板数占野生型DNA 模板数的20%);Taqman探针技术保障了试剂盒的检测为闭管反应,有效的避免了假阳性的产生,其检测特异性也充分得到保证,而且检测快速方便,整个检测过程只有80分钟,而直接测序则需要2 天的时间,而且是开管操作,PCR产物污染的可能性大增。The advantages of the present invention are: the kit is simple to operate, low in cost, simple and easy to judge results, and high in sensitivity. The sensitivity of the kit to detect gene mutations can reach 1% (that is, the number of mutant gene DNA templates of the target gene accounts for 1% of the number of wild-type DNA templates). 1% of the number of DNA templates); while the sensitivity of detecting gene mutations in direct sequencing is 20% (that is, the number of mutant gene DNA templates of the target gene accounts for 20% of the number of wild-type DNA templates); Taqman probe technology ensures the kit’s The detection is a closed-tube reaction, which effectively avoids false positives, and its detection specificity is fully guaranteed, and the detection is fast and convenient. The entire detection process only takes 80 minutes, while direct sequencing takes 2 days, and it is an open-tube method. operation, the possibility of PCR product contamination is greatly increased.
本发明中PCR(Past-PCR)的实施步骤:Implementation steps of PCR (Past-PCR) in the present invention:
1.阳性质粒的构建1. Construction of positive plasmid
在待检测的JAK2基因V617F多态性位点的上下游设计一对PCR引物,其扩增片段的长度可在500bp的范围内,用gDNA为模板,采用常规PCR方法,扩增出这一片段,通过AT克隆的方式,将该片段克隆至测序的质粒中,通常用Invitrogen的pCR2.1 Topo T载体试剂盒,操作按说明书进行,也可用其他厂家的T载体试剂盒,甚至可用自己制备的T载体质粒。得到的阳性克隆,经测序验证,证明序列的正确性,然后采用Stratagene 公司的Quickchange试剂盒,设计对应位点的另一个基因型引物,通过Quickchange的方法,得到该突变型别的阳性克隆,操作按说明书进行,所得到的阳性质粒都必须经测序验证为正确方可进入下一步的使用。Taqman定量质粒,并用作模板以验证给定的测定法的灵敏性、线性动态范围、特异性。Design a pair of PCR primers upstream and downstream of the V617F polymorphic site of the JAK2 gene to be detected. The length of the amplified fragment can be within the range of 500bp. Using gDNA as a template, the conventional PCR method is used to amplify this fragment , by means of AT cloning, clone the fragment into the sequenced plasmid, usually use Invitrogen’s pCR2.1 Topo T vector kit, the operation is carried out according to the instructions, T vector kits from other manufacturers can also be used, or even self-prepared T vector plasmid. The positive clone obtained was verified by sequencing to prove the correctness of the sequence, and then the Stratagene company’s Quickchange kit was used to design another genotype primer corresponding to the site, and the positive clone of the mutant type was obtained by the Quickchange method, and the operation According to the instructions, the obtained positive plasmids must be verified to be correct by sequencing before they can be used in the next step. Taqman quantifies the plasmid and is used as a template to validate the sensitivity, linear dynamic range, specificity of a given assay.
2.等位基因特异性引物(ASP)的设计和筛选2. Design and screening of allele-specific primers (ASP)
在引物3’末端互补于对应的基因突变碱基位点,而在引物3’末端倒数第二位或第三位引入碱基错配,或第二和第三位的连续错配;针对不同的多态性或突变位点,在引物3’端倒数第二位或第三位引入碱基错配的基础上,还可在引物的其它位点增加碱基错配来满足反应特异性的要求,越远离3’端,增加错配的碱基数越多,在5’端可达最多的等位基因1特异性引物。The 3' end of the primer is complementary to the corresponding gene mutation base site, and a base mismatch is introduced at the penultimate or third position of the primer 3' end, or the second and third consecutive mismatches; for different The polymorphism or mutation site, on the basis of introducing a base mismatch at the penultimate or third position of the 3' end of the primer, base mismatches can also be added at other positions of the primer to meet the specificity of the reaction. Requirements, the farther away from the 3' end, the more bases that increase the number of mismatches, and the most accessible allele 1-specific primers at the 5' end.
ASP的筛选是利用构建好的野生型和突变型重组质粒,分别进行荧光定量PCR反应的交叉筛选,即当用突变引物与野生型的模板进行扩增时,与用野生型引物同野生型模板的反应要多用19个循环数以上,反之亦然,那么这样的引物就具备高度的特异性。将筛选出的特异性引物用与对应的重组质粒作敏感性试验,检测灵敏度小于10-1000个拷贝的引物即达到检测的灵敏度要求,满足上述两个条件的引物就是我们选出的ASP引物,可进行下一步的检测。ASP screening is to use the constructed wild-type and mutant recombinant plasmids to carry out cross-screening of fluorescent quantitative PCR reactions, that is, when using mutant primers and wild-type templates to amplify, the same as using wild-type primers and wild-type templates. The reaction should use more than 19 cycles, and vice versa, then such primers have a high degree of specificity. Use the screened specific primers with the corresponding recombinant plasmids for a sensitivity test. The primers with a detection sensitivity of less than 10-1000 copies meet the detection sensitivity requirements. The primers that meet the above two conditions are the ASP primers we selected. The next step of detection can be carried out.
3.扩增试剂准备及加入被检测样品3. Preparation of amplification reagents and addition of tested samples
(1)从试剂盒中取出各组成成分,室温缓慢融化PCR缓冲液、dNTPs和Taq酶混合液、阳性质控品、空白对照,颠倒摇匀。每个反应管需加入PCR缓冲液、Taq酶(dNTPs)、灭菌超纯水和DNA样本。盖紧管盖,瞬时离心后转移到PCR扩增区。(1) Take out the components from the kit, slowly melt the PCR buffer, dNTPs and Taq enzyme mixture, positive quality control, and blank control at room temperature, and shake them upside down. Each reaction tube needs to add PCR buffer, Taq enzyme (dNTPs), sterilized ultrapure water and DNA sample. Cap the tube tightly, centrifuge briefly and transfer to the PCR amplification area.
(2)建议每次PCR反应均同时进行样本、阳性质控品、空白对照的分析,阳性质控品和空白对照的加样方法同样本加入方法。(2) It is recommended that the analysis of samples, positive quality control products, and blank control be carried out at the same time for each PCR reaction, and the sample addition method of positive quality control material and blank control is the same as the sample addition method.
4.反应条件4. Reaction conditions
每个反应管中 (反应终体积的范围可在10-50μl,最佳在20-25μl反应体积)包含PCR缓冲液(10mM Tris-HCl pH8.3,50mM KCl, 0.1%Triton X-100,2.0mM MgCl2),10-100ng DNA或1,000,000个拷贝的质粒DNA,50nM-400nM 一个共同的通用特异性Taqman探针,一个50nM-2uM共同的通用反向特异性下游引物,50nM-2uM不同等位基因特异性上游引物,1pm-20pm检测管家基因GAPDH的上游引物,1pm-20pm检测管家基因GAPDH的下游引物,0.05pm-5pm检测管家基因GAPDH的探针,再加上1.5单位Taq聚合酶,200μM dNTPs。Each reaction tube (the final volume of the reaction can be in the range of 10-50 μl, the optimal reaction volume of 20-25 μl) contains PCR buffer (10mM Tris-HCl pH8.3, 50mM KCl, 0.1%Triton X-100, 2.0 mM MgCl 2 ), 10-100ng DNA or 1,000,000 copies of plasmid DNA, 50nM-400nM a common universal specificity Taqman probe, a 50nM-2uM common universal specificity downstream primer, 50nM-2uM different alleles Gene-specific upstream primers, 1pm-20pm detect the upstream primer of the housekeeping gene GAPDH, 1pm-20pm detect the downstream primer of the housekeeping gene GAPDH, 0.05pm-5pm detect the probe of the housekeeping gene GAPDH, plus 1.5 units of Taq polymerase, 200μM dNTPs.
1)、循环条件设置1), cycle condition setting
为使荧光曲线更加美观,建议从第二步开始收集荧光信号。In order to make the fluorescence curve more beautiful, it is recommended to collect the fluorescence signal from the second step.
2)、仪器检测通道选择2), instrument detection channel selection
荧光信号采集温度设为60℃,具体设置方法请参照相应仪器使用说明书。The fluorescence signal acquisition temperature is set to 60°C, please refer to the instruction manual of the corresponding instrument for the specific setting method.
3)、检测类型设定:空白对照设为“NTC”,阳性质控品和待检样本设为“Unknown”。3) Detection type setting: set the blank control to "NTC", set the positive quality control and the sample to be tested to "Unknown".
5.结果分析5. Result Analysis
如果检测样本仅有突变型反应管在FAM通道有对数增长的扩增曲线,同时VIC通道有对数增长的扩增曲线,可判定样本为T型,即突变型纯合子;如果检测样本仅有野生型反应管在FAM通道有对数增长的扩增曲线,同时VIC通道有对数增长的扩增曲线,可判定样本为G型,即野生型纯合子;如果检测样本突变型和野生型反应管在FAM通道均有对数增长的扩增曲线,同时VIC通道有对数增长的扩增曲线,可判定样本为TG型,即杂合子;由于本方法结果是“全或无”,结果极易判断,哪一个管有反应,哪一个管就是阳性。If the test sample only has a logarithmic growth amplification curve in the FAM channel of the mutant reaction tube, and at the same time, the VIC channel has a logarithmic growth amplification curve, it can be determined that the sample is T-type, that is, mutant homozygosity; If there is a wild-type reaction tube with a logarithmic growth amplification curve in the FAM channel, and a logarithmic growth amplification curve in the VIC channel, it can be determined that the sample is G type, that is, wild-type homozygosity; if the test sample mutant and wild type The reaction tubes have a logarithmic growth amplification curve in the FAM channel, and at the same time, the VIC channel has a logarithmic growth amplification curve, which can determine that the sample is a TG type, that is, a heterozygote; since the result of this method is "all or none", the result It is very easy to judge which tube has a reaction and which tube is positive.
具体实施例specific embodiment
下面以对JAK2基因V617F多态性位点检测的情形为例,具体对本发明作进一步详细的说明。Taking the detection of the V617F polymorphic site of the JAK2 gene as an example, the present invention will be further described in detail below.
实施例1:针对JAK2基因V617F多态性位点的野生型和突变型阳性质粒的制备Example 1: Preparation of wild type and mutant positive plasmids for JAK2 gene V617F polymorphic site
JAK是一种非受体型酪氨酸蛋白激酶,其中JAK2突变与骨髓增生性疾病的密切关系,JAK2 基因V617F突变可导致JAK-STAT信号通路的异常激活,导致骨髓细胞产生异常增殖,在修订的2008世界卫生组织(WHO)分类系统中,JAK2突变成为慢性骨髓增殖性疾病(MPD)主要的诊断指标。JAK is a non-receptor tyrosine protein kinase, among which JAK2 mutation is closely related to myeloproliferative diseases. JAK2 gene V617F mutation can lead to abnormal activation of JAK-STAT signaling pathway, resulting in abnormal proliferation of bone marrow cells. In the 2008 World Health Organization (WHO) classification system, JAK2 mutation has become the main diagnostic index of chronic myeloproliferative disease (MPD).
首先我们从基因库中调出JAK2基因的V617F多态性位点前后的基因序列,并将多态性位点用双下划线标记,在JAK2基因的V617F多态性位点的上下游适当位置(用黑体字和下划线标示),设计一对克隆引物,扩增片段为228bp,突变位点包含其内,基因序列显示如下,SEQ No.1:First, we called out the gene sequence before and after the V617F polymorphic site of the JAK2 gene from the gene bank, and marked the polymorphic site with a double underline, at the appropriate position upstream and downstream of the V617F polymorphic site of the JAK2 gene ( Marked in bold and underlined), design a pair of cloning primers, the amplified fragment is 228bp, including the mutation site, the gene sequence is shown below, SEQ No.1:
catgattcctgtaccactcttgctctctctcactttgatctccatattccaggcttacacaggggtttcctcagaacgttgatggcagttgcaggtccatataaagggaccaaagcacattgtatcctcatctatagtcatgctgaaagtaggagaaagtgcatctttattatggcagagagaattttctgaactatttatggacaacagtcaaacaacaattctttgtacttttttttttccttagtctttctttgaagcagcaagtatgatgagcaagctttctcacaagcatttggttttaaattatggagtatgtgtctgtggagacgagagtaagtaaaactacaggctttctaatgcctttctcagagcatctgtttttgtttatatagaaaattcagtttcaggatcacagctaggtgtcagtgtaaactataatttaacaggagttaagtatttttgaaactgaaaacactgtaggactattcagttatatcttgtgaaaaaggaaagcaatgaagttaaaagtagaaggttacaatgcccaaacaatagagtattcatgattcctgtaccactcttgctctctctcactttgatctccatattccaggcttacacaggggtttcctcagaacgttgatggcagttgcaggtccatataaagggaccaaagcacattgtatcctcatctatagtcatgctgaaagtaggagaaagtgcatctttattatggcagagagaattttctgaactatttat ggacaacagtcaaacaacaattc tttgtacttttttttttccttagtctttctttgaagcagcaagtatgatgagcaagctttctcacaagcatttggttttaaattatggagtatgt g tctgtggagacgagagtaagtaaaactacaggctttctaatgcctttctcagagcatctgtttttgtttatatagaaaattcagttt caggatcacagctaggtgtcag tgtaaactataatttaacaggagttaagtatttttgaaactgaaaacactgtaggactattcagttatatcttgtgaaaaaggaaagcaatgaagttaaaagtagaaggttacaatgcccaaacaatagagtatt
实验步骤如下:The experimental steps are as follows:
1)提取基因组DNA1) Genomic DNA extraction
用国内天根公司或Qiagen公司的基因组DNA提取试剂盒,提取基因组DNA,具体操作步骤按说明书进行。制备好的DNA标本,经紫外分光光度计测定浓度,将其浓度调整到50ng/μl,保存于-20℃,或直接进行下面的反应。Genomic DNA was extracted with Genomic DNA Extraction Kit from domestic Tiangen Company or Qiagen Company, and the specific operation steps were carried out according to the instructions. The prepared DNA samples were tested for concentration by UV spectrophotometer, adjusted to 50ng/μl, stored at -20°C, or directly proceeded to the following reaction.
2)AT克隆获得阳性质粒2) AT clones obtain positive plasmids
首先在突变点上下游设计克隆引物,见表1:First, design cloning primers upstream and downstream of the mutation point, as shown in Table 1:
表1.JAK2基因V617F多态性位点野生型克隆引物Table 1. Primers for wild-type cloning of JAK2 gene V617F polymorphism site
在12.5μl 的2×PCR Master Mix (Fermentas) 的PCR扩增体系,加入10μM上游引物和10μM下游引物,以及基因组DNA50ng,加水至总体积25μl,PCR反应条件设定为95℃预变性3min,95℃变性10s,60℃退火及延伸30s,总共35个循环,反应结束后取15μl反应产物,进行浓度2.5%的凝胶电泳,电泳结束后观察,条带与预测的大小相符,表明扩增成功。采用美国Life公司的pCR2.0 TOPO T载体,按其操作说明,通过TA克隆的方式,获得JAK2基因V617F多态性位点野生型阳性质粒,具体的基因序列如下,其中多态性位点显示为G型,说明为野生型,测序证明所获质粒正确。In 12.5 μl of 2×PCR Master Mix (Fermentas) PCR amplification system, add 10 μM upstream primers and 10 μM downstream primers, and 50 ng of genomic DNA, add water to a total volume of 25 μl, and set the PCR reaction conditions at 95°C for pre-denaturation for 3 minutes, 95 Denaturation at ℃ for 10 s, annealing at 60 ℃ and extension for 30 s, a total of 35 cycles. After the reaction, take 15 μl of the reaction product and perform gel electrophoresis at a concentration of 2.5%. After the electrophoresis, the band is consistent with the predicted size, indicating that the amplification is successful . Using the pCR2.0 TOPO T vector from American Life Company, according to its operating instructions, the wild-type positive plasmid of the V617F polymorphic site of the JAK2 gene was obtained by TA cloning. The specific gene sequence is as follows, where the polymorphic site is shown It is G type, indicating that it is wild type, and the sequencing proves that the obtained plasmid is correct.
SEQNo.4:ggacaacagtcaaacaacaattctttgtacttttttttttccttagtctttctttgaagcagcaagtatgatgagcaagctttctcacaagcatttggttttaaattatggagtatgtgtctgtggagacgagagtaagtaaaactacaggctttctaatgcctttctcagagcatctgtttttgtttatatagaaaattcagtttcaggatcacagctaggtgtcagSEQNo.4:ggacaacagtcaaacaacaattctttgtacttttttttttccttagtctttctttgaagcagcaagtatgatgagcaagctttctcacaagcatttggttttaaattatggagtatgt g tctgtggagacgagagtaagtaaaactacaggctttctaatgcctttctcagagcatctgtttttgtttatatagaaaattcagtttcaggatcacagctaggtgtcag
3)快速突变法获得突变质粒3) Rapid mutation method to obtain mutant plasmids
然后,采用产生快速突变的方法(Quickchange, QC),设计突变引物,由于JAK2-V617F位点为g至t的变化,引物序列见表2。Then, use the method of quick mutation (Quickchange, QC) to design mutation primers. Since the JAK2-V617F site changes from g to t, the primer sequences are shown in Table 2.
表2. 获得JAK2基因V617F多态性位点突变型克隆引物Table 2. Cloning primers for the V617F polymorphism site mutation of the JAK2 gene
按照(Stratagene公司)Quickchange 试剂盒的反应条件和步骤,完成突变体的构建,所得到的重组质粒,具体的基因序列如下,经测序验证其中多态性位点显示为t,为突变型,然后将突变型与野生型质粒分别置-20℃保存备用。According to the reaction conditions and steps of the (Stratagene Company) Quickchange kit, the construction of the mutant was completed. The specific gene sequence of the obtained recombinant plasmid was as follows. It was verified by sequencing that the polymorphic site was shown as t, which was a mutant type, and then Store the mutant and wild-type plasmids separately at -20°C for future use.
SEQ No.7:ggacaacagtcaaacaacaattctttgtacttttttttttccttagtctttctttgaagcagcaagtatgatgagcaagctttctcacaagcatttggttttaaattatggagtatgtttctgtggagacgagagtaagtaaaactacaggctttctaatgcctttctcagagcatctgtttttgtttatatagaaaattcagtttcaggatcacagctaggtgtcagSEQ No.7:ggacaacagtcaaacaacaattctttgtacttttttttttccttagtctttctttgaagcagcaagtatgatgagcaagctttctcacaagcatttggttttaaattatggagtatgt t tctgtggagacgagagtaagtaaaactacaggctttctaatgcctttctcagagcatctgtttttgtttatatagaaaattcagtttcaggatcacagctaggtgtcag
实施例2:等位基因特异性引物(ASP)的设计和特异性筛选Example 2: Design and specificity screening of allele-specific primers (ASP)
针对JAK2-V617F,设计野生型和一系列突变特异型引物如下:For JAK2-V617F, design wild-type and a series of mutant-specific primers as follows:
JAK2-V617F-WT-R:ttacttactctcgtctccacacac(SEQ No.8)JAK2-V617F-WT-R: ttacttactctcgtctccacacac (SEQ No. 8)
JAK2-V617F-mut-R:tttacttactctcgtctccacacaa(SEQ No.9)JAK2-V617F-mut-R: tttacttactctcgtctccacacaa (SEQ No. 9)
JAK2-V617F-mut-R1: tacttactctcgtctccacacaa(SEQ No.10)JAK2-V617F-mut-R1: tacttactctcgtctccacacaa (SEQ No. 10)
JAK2-V617F-mut-R2: acttactctcgtctccacacaa(SEQ No.11)JAK2-V617F-mut-R2: acttactctcgtctccacacaa (SEQ No. 11)
JAK2-V617F-mut-R3: ctttacttactctcgtctccacagga(SEQ No.12)JAK2-V617F-mut-R3: ctttacttactctcgtctccacagga (SEQ No. 12)
JAK2-V617F-mut-R4:cttacttactctcgtctccacagga(SEQ No.13)JAK2-V617F-mut-R4:cttacttactctcgtctccacagga (SEQ No. 13)
JAK2-V617F-mut-R5:ctacttactctcgtctccacagga(SEQ No.14)JAK2-V617F-mut-R5: ctacttactctcgtctccacagga (SEQ No. 14)
同时设计合成Taqman 特异性探针:Simultaneously design and synthesize Taqman-specific probes:
SEQ No.15:FAM-tgaagcagcaagtatgatgagcaagc-BHQ1。SEQ No. 15: FAM-tgaagcagcaagtatgatgagcaagc-BHQ1.
相关引物和探针在生工生物工程(上海)有限公司进行合成。Relevant primers and probes were synthesized at Sangon Bioengineering (Shanghai) Co., Ltd.
然后分别用上述7条引物与JAK2基因的共同下游引物JAK2-V617F-F:5’-ggacaacagtcaaacaacaattc-3’(SEQ No.16)引物配对,加上Taqman 特异性探针,加入前述构建所得到的野生型重组质粒约3万个拷贝为模板,在荧光定量PCR仪上进行引物特异性筛选,反应条件设定为第一步95℃2min 预变性, 95℃5s, 63℃30s 共15个循环,不收集荧光信号,第二步95℃5s,60℃30s 共40个循环,收集荧光信号,结果见图1。Then use the above 7 primers to pair with the common downstream primer JAK2-V617F-F: 5'-ggacaacagtcaaacaacaattc-3' (SEQ No.16) of the JAK2 gene, and add Taqman-specific probes to add the obtained About 30,000 copies of the wild-type recombinant plasmid were used as templates, and primer specificity screening was carried out on a fluorescent quantitative PCR instrument. The reaction conditions were set as the first step of 95°C for 2min pre-denaturation, 95°C for 5s, and 63°C for 30s for a total of 15 cycles. No fluorescence signal was collected, the second step was 95°C for 5s and 60°C for 30s for a total of 40 cycles to collect the fluorescence signal, the results are shown in Figure 1.
其中,图1中1~7曲线分别代表JAK2-V617F-WT-R、JAK2-V617F-mut-R、JAK2-V617F-mut-R1、JAK2-V617F-mut-R2、JAK2-V617F-mut-R3、JAK2-V617F-mut-R4、JAK2-V617F-mut-R5的PCR扩增曲线,从图1中我们看出1号野生型引物在7个循环产生扩增信号,2-6引物的特异性较差,分别在7.5-9个循环时产生非特异性扩增,同野生型引物(1号)扩增效率相差小于19个循环,第7号引物满足我们的要求,在40个循环时,仍然没有扩增,同野生型引物扩增效率相差大于19个循环。为了与突变引物有更好的可比性,我们参照第7号引物重新设计野生型的引物为:ctacttactctcgtctccacaggc(SEQ No.17)。Among them, the curves 1~7 in Figure 1 represent JAK2-V617F-WT-R, JAK2-V617F-mut-R, JAK2-V617F-mut-R1, JAK2-V617F-mut-R2, JAK2-V617F-mut-R3 , JAK2-V617F-mut-R4, and JAK2-V617F-mut-R5 PCR amplification curves, from Figure 1 we can see that No. 1 wild-type primer generates amplification signals in 7 cycles, and the specificity of 2-6 primers Poor, non-specific amplification occurs at 7.5-9 cycles respectively, and the difference in amplification efficiency with the wild-type primer (No. 1) is less than 19 cycles. Primer No. 7 meets our requirements. At 40 cycles, it is still There is no amplification, and the difference between the amplification efficiency of the wild-type primer is more than 19 cycles. In order to have better comparability with the mutant primers, we redesigned the wild-type primers with reference to primer No. 7: ctacttactctcgtctccacaggc (SEQ No. 17).
实施例3:ASP灵敏度筛选Embodiment 3: ASP sensitivity screening
再用7号突变型引物同JAK2基因的共同下游引物SEQ No.16配对,用突变型重组质粒,按照106,105,104,103,102,10,0作梯度稀释,加上Taqman 特异性探针,在荧光定量PCR仪上进行灵敏度验证。该7号突变特异型引物能检测出100个拷贝的突变体,因此这一引物就是按我们的方法筛选出检测JAK2基因的V617F多态性位点的最佳引物,见表3所示。Then use the No. 7 mutant primer to pair with the common downstream primer SEQ No.16 of the JAK2 gene, use the mutant recombinant plasmid, make gradient dilutions according to 10 6 , 10 5 , 10 4 , 10 3 , 10 2 , 10,0, add Use Taqman specific probes, and perform sensitivity verification on a fluorescent quantitative PCR instrument. The No. 7 mutation-specific primer can detect 100 copies of the mutant, so this primer is the best primer for detecting the V617F polymorphism site of the JAK2 gene screened according to our method, as shown in Table 3.
实施例4:预制的本发明PCR(Past-PCR)反应管Embodiment 4: Prefabricated PCR (Past-PCR) reaction tube of the present invention
按照每个突变位点两个反应管的要求,即一管检测野生型位点,另一管检测突变位点,将适宜浓度的引物探针预先包被于0.2ML乳白色的PCR反应管中。According to the requirements of two reaction tubes for each mutation site, that is, one tube for detection of wild-type site and the other tube for detection of mutation site, pre-coat the appropriate concentration of primer probes in a 0.2ML milky white PCR reaction tube.
为了防止检测时出现假阴性,在每个反应管中均预先包被有检测管家基因GAPDH的上游引物、下游引物和探针,其中,GAPDH基因序列如下:In order to prevent false negatives during detection, each reaction tube is pre-coated with upstream primers, downstream primers and probes for the detection of the housekeeping gene GAPDH, wherein the sequence of the GAPDH gene is as follows:
cctccgggaaactgtggcgtgatggccgcggggctctccagaacatcatccctgcctctactggcgctgccaaggctgtgggcaaggtcatccctgagctgaacgggaagctcactggcatggccttccgtgtccccactgccaacgtgtcagtggtggacctgacctgccgtctagaaaaacctgccaaatatgatgacatcaagaaggtggtgaagcaggcgtcggagggccccctcaagggcatcctgggctacactgagcaccaggtggtctcctctgacttcaacagcgacacccactcctccacctttgacgctggggctggcattgccctcaacg(SEQ No.18)cctccgggaaactgtggcgtgatggccgcggggctctccagaacatcatccctgcctctactggcgctgccaaggctgtgggcaaggtcatccctgagctgaacgggaagctcactggcatggccttccgtgtccccactgccaacgtgtcagtggtggacctgacctgccgtctagaaaaacctgccaaatatgatgacatcaagaaggtggtgaagcaggcgtcggagggccccctcaagggcatcctgggctacactgagcaccaggtggtctcctctgacttcaacagcgacacccactcctccacctttgacgctggggctggcattgccctcaacg(SEQ No.18)
检测管家基因GAPDH的上游引物序列为:ggctgtgggcaaggtcatc(SEQ No.19)The upstream primer sequence for detecting the housekeeping gene GAPDH is: ggctgtgggcaaggtcatc (SEQ No.19)
检测管家基因GAPDH的下游引物序列为:ctccgacgcctgcttcaccac(SEQ No.20)The downstream primer sequence for detecting the housekeeping gene GAPDH is: ctccgacgcctgcttcaccac (SEQ No.20)
检测管家基因GAPDH的探针序列为:ccttccgtgtccccactgccaacgt(SEQ No.21)The probe sequence for detecting the housekeeping gene GAPDH is: ccttccgtgtccccactgccaacgt (SEQ No.21)
其中,检测管家基因GAPDH的探针5’端用HEX荧光标记,3’端用BHQ标记,由于HEX和VIC属于同一通道检测,而许多仪器往往采用VIC标示,因此文中用VIC叙述。Among them, the 5' end of the probe for detecting the housekeeping gene GAPDH is labeled with HEX fluorescence, and the 3' end is labeled with BHQ. Since HEX and VIC belong to the same channel for detection, and many instruments often use VIC labeling, VIC is used for description in this article.
PCR反应管中具体的细节见表3。The specific details in the PCR reaction tube are shown in Table 3.
表3. 预制JAK2基因V617F多态性位点Past-PCR反应管的组分和浓度Table 3. Components and concentrations of premade JAK2 gene V617F polymorphic site Past-PCR reaction tubes
由于我们预先把突变型和野生型上游引物、探针和共同下游引物、检测管家基因GAPDH的上、下游引物和检测管家基因GAPDH的探针包被在编好号的不同反应管中,有效避免了使用者的操作误差,同时大大提高了操作效率,极大方便了在临床上的实际使用。Because we prepackage the mutant and wild-type upstream primers, probes and common downstream primers, the upstream and downstream primers for detecting the housekeeping gene GAPDH, and the probe for detecting the housekeeping gene GAPDH in different numbered reaction tubes, effectively avoiding The user's operation error is reduced, and the operation efficiency is greatly improved at the same time, which greatly facilitates the actual clinical use.
实施例5:标本的验证Embodiment 5: verification of specimen
采集黑色素瘤病人的组织标本,并用Qiagen公司的基因组DNA提取试剂盒,提取基因组DNA,具体操作步骤按说明书进行。制备好的DNA标本,经紫外分光光度计测定浓度,将其浓度调整到100ng/μl备用。Tissue samples of melanoma patients were collected, and genomic DNA was extracted using the genomic DNA extraction kit of Qiagen Company, and the specific operation steps were carried out according to the instructions. The concentration of the prepared DNA sample was measured by an ultraviolet spectrophotometer, and the concentration was adjusted to 100ng/μl for later use.
我们用筛选出的这个突变特异性引物,同时用野生型引物作对照,在同一个PCR反应板上,每两个反应管检测一个基因位点,其中一个是突变位点,另一个是野生型位点。每个反应管20μl反应体积中包含10mM Tris-HCl pH8.3,50mM KCl,0.1%Triton X-100,2.0mMMgCl2,100ng黑色素瘤病人的DNA,100nM特异性Taqman探针,500nM共用特异性下游引物,及500nM野生型特异性引物,或突变型特异性引物,5pm检测管家基因GAPDH的上游引物,5pm检测管家基因GAPDH的下游引物,2.5pm检测管家基因GAPDH的探针,再加上1.5单位Taq DNA聚合酶,200μM dNTPs,其余为去离子水。We use the mutation-specific primers screened out, and use wild-type primers as controls at the same time. On the same PCR reaction plate, every two reaction tubes detect a gene locus, one of which is the mutation site and the other is the wild-type site. Each reaction tube contains 10mM Tris-HCl pH8.3, 50mM KCl, 0.1%Triton X-100, 2.0mM MgCl 2 , 100ng melanoma patient DNA, 100nM specific Taqman probe, 500nM shared specificity downstream in 20μl reaction volume Primers, and 500nM wild-type specific primers, or mutant-specific primers, 5pm upstream primers to detect the housekeeping gene GAPDH, 5pm downstream primers to detect the housekeeping gene GAPDH, 2.5pm probes to detect the housekeeping gene GAPDH, plus 1.5 units Taq DNA polymerase, 200μM dNTPs, the rest is deionized water.
第一步PCR反应条件是:37℃2min,95℃2min预变性,然后95℃5s,63℃30s ,15个循环,此步不收集荧光;第二步PCR反应条件是:95℃5s,60℃30s,共40个循环,此步收集荧光。为了方便起见,我们将JAK2基因的V617F多态性正常位点认定为野生型(G位点),而容易引起JAK-STAT信号通路的异常激活的位点则为突变型(T位点),如果对应的反应管有信号增长,就判断为对应的纯合基因型,如两管均发生增长,则为杂合型。The first step PCR reaction conditions are: 37°C for 2min, 95°C for 2min pre-denaturation, then 95°C for 5s, 63°C for 30s, 15 cycles, this step does not collect fluorescence; the second step PCR reaction conditions are: 95°C for 5s, 60°C ℃ for 30s, a total of 40 cycles, this step collects fluorescence. For convenience, we identified the normal site of the V617F polymorphism of the JAK2 gene as the wild type (G site), and the site that is likely to cause abnormal activation of the JAK-STAT signaling pathway as the mutant type (T site). If the corresponding reaction tube has signal growth, it is judged as the corresponding homozygous genotype, and if both tubes grow, it is heterozygous.
1、按照上述方法进行检测下列突变型基因序列:1. According to the above method, detect the following mutant gene sequences:
SEQ No.22:tggagtatgtttctgtggagaSEQ No.22: tggagtatgtttctgtggaga
收集到的FAM通道PCR扩增曲线图,如图2所示,其中,a曲线代表检测突变型PCR反应管中的扩增曲线,b曲线代表检测野生型PCR反应管中的扩增曲线。The collected FAM channel PCR amplification curves are shown in Figure 2, wherein, curve a represents the amplification curve in the detection mutant PCR reaction tube, and curve b represents the amplification curve in the detection wild-type PCR reaction tube.
2、按照上述方法进行检测下列野生型基因序列:2. Detect the following wild-type gene sequences according to the above method:
SEQ No.23:tggagtatgtgtctgtggagaSEQ No.23: tggagtatgtg tctgtggaga
收集到的FAM通道PCR扩增曲线图,如图3所示,其中,c曲线代表检测野生型PCR反应管中的扩增曲线,d曲线代表检测突变型PCR反应管中的扩增曲线。The collected FAM channel PCR amplification curve is shown in FIG. 3 , wherein, the c curve represents the amplification curve in the detection wild-type PCR reaction tube, and the d curve represents the amplification curve in the detection mutant PCR reaction tube.
3、按照上述方法进行杂合(TG型)检测,其具体基因序列为:3. Perform heterozygous (TG type) detection according to the above method, and the specific gene sequence is:
SEQ No.24:tggagtatgttt/gtctgtggagaSEQ No.24: tggagtatgtt t/g tctgtggaga
收集到的FAM通道PCR扩增曲线图,如图4所示,其中,e曲线代表检测野生型PCR反应管中的扩增曲线,f曲线代表检测突变型PCR反应管中的扩增曲线。The collected FAM channel PCR amplification curves are shown in Figure 4, wherein the e curve represents the amplification curve in the detection wild-type PCR reaction tube, and the f curve represents the amplification curve in the detection mutant PCR reaction tube.
同时,上述3个检测案例中,当VIC通道管家基因GAPDH有对数增长的扩增曲线,如图5所示,同时FAM通道有对数增长的扩增曲线,则此次实验结果有效。At the same time, in the above three detection cases, when the VIC channel housekeeping gene GAPDH has a logarithmic growth amplification curve, as shown in Figure 5, and the FAM channel has a logarithmic growth amplification curve, the experimental results are valid.
因此,从上述的检测试验可见,本试剂盒的检测结果为“全或无”的结果,即若被检测样品为突变等位基因纯合子,两个PCR反应管中,仅有突变型PCR反应管在FAM通道和VIC通道均有对数增长的扩增曲线,而野生型PCR反应管在FAM通道毫无对数增长的扩增曲线;若被检测样品为野生等位基因纯合子,两个PCR反应管中,仅有野生型PCR反应管在FAM通道和VIC通道均有对数增长的扩增曲线,而突变型PCR反应管在FAM通道毫无对数增长的扩增曲线;若被检测样品为杂合子,两个PCR反应管中均有在FAM通道和VIC通道均有对数增长的扩增曲线。该试剂盒的检测结果判读简单,减少了以往试剂盒的检测结果需要进行ΔCt等一系列复杂计算的过程,降低错判率,同时还有效避免了以往试剂盒检测结果中存在假阴性假阳性现象的发生。此外本发明提供的试剂盒可用于任何型号的荧光定量PCR仪,检测仪器简单,成本低,为科研和临床JAK2基因分型和基因突变分析提供了强有力的工具。Therefore, it can be seen from the above-mentioned detection test that the detection result of this kit is an "all or none" result, that is, if the tested sample is homozygous for the mutant allele, only the mutant PCR reaction will be detected in the two PCR reaction tubes. Both tubes have logarithmic growth amplification curves in the FAM channel and VIC channel, while the wild-type PCR reaction tube has no logarithmic growth amplification curve in the FAM channel; if the tested sample is homozygous for the wild allele, two Among the PCR reaction tubes, only the wild-type PCR reaction tube has a logarithmic growth amplification curve in the FAM channel and the VIC channel, while the mutant PCR reaction tube has no logarithmic growth amplification curve in the FAM channel; if detected The sample is heterozygous, and there are amplification curves with logarithmic growth in both the FAM channel and the VIC channel in the two PCR reaction tubes. The detection results of the kit are easy to interpret, which reduces the need for a series of complex calculations such as ΔCt in the detection results of the previous kits, reduces the misjudgment rate, and effectively avoids false negatives and false positives in the detection results of the previous kits happened. In addition, the kit provided by the present invention can be used in any type of fluorescent quantitative PCR instrument, the detection instrument is simple, and the cost is low, which provides a powerful tool for scientific research and clinical JAK2 genotyping and gene mutation analysis.
序列表sequence listing
<110> 沈阳优吉诺生物科技有限公司<110> Shenyang Youjinuo Biotechnology Co., Ltd.
<120> 检测JAK2基因V617F位点多态性的引物、试剂盒及其PCR方法<120> Primers, kit and PCR method for detecting JAK2 gene V617F polymorphism
<130> 2015<130> 2015
<160> 24<160> 24
<170> PatentIn version 3.3<170> PatentIn version 3.3
<210> 1<210> 1
<211> 564<211> 564
<212> DNA<212>DNA
<213> 人工合成<213> Synthetic
<400> 1<400> 1
catgattcct gtaccactct tgctctctct cactttgatc tccatattcc aggcttacac 60catgattcct gtaccactct tgctctctct cactttgatc tccatattcc aggcttacac 60
aggggtttcc tcagaacgtt gatggcagtt gcaggtccat ataaagggac caaagcacat 120aggggtttcc tcagaacgtt gatggcagtt gcaggtccat ataaagggac caaagcacat 120
tgtatcctca tctatagtca tgctgaaagt aggagaaagt gcatctttat tatggcagag 180tgtatcctca tctatagtca tgctgaaagt aggagaaagt gcatctttat tatggcagag 180
agaattttct gaactattta tggacaacag tcaaacaaca attctttgta cttttttttt 240agaattttct gaactattta tggacaacag tcaaacaaca attctttgta cttttttttt 240
tccttagtct ttctttgaag cagcaagtat gatgagcaag ctttctcaca agcatttggt 300tccttagtct ttctttgaag cagcaagtat gatgagcaag ctttctcaca agcatttggt 300
tttaaattat ggagtatgtg tctgtggaga cgagagtaag taaaactaca ggctttctaa 360tttaaattat ggagtatgtg tctgtggaga cgagagtaag taaaactaca ggctttctaa 360
tgcctttctc agagcatctg tttttgttta tatagaaaat tcagtttcag gatcacagct 420tgcctttctc agagcatctg tttttgttta tatagaaaat tcagtttcag gatcacagct 420
aggtgtcagt gtaaactata atttaacagg agttaagtat ttttgaaact gaaaacactg 480aggtgtcagt gtaaactata atttaacagg agttaagtat ttttgaaact gaaaacactg 480
taggactatt cagttatatc ttgtgaaaaa ggaaagcaat gaagttaaaa gtagaaggtt 540taggactatt cagttatatc ttgtgaaaaa ggaaagcaat gaagttaaaa gtagaaggtt 540
acaatgccca aacaatagag tatt 564acaatgccca aacaatagag tatt 564
<210> 2<210> 2
<211> 23<211> 23
<212> DNA<212>DNA
<213> 人工合成<213> Synthetic
<400> 2<400> 2
ggacaacagt caaacaacaa ttc 23ggacaacagt caaacaacaa ttc 23
<210> 3<210> 3
<211> 22<211> 22
<212> DNA<212>DNA
<213> 人工合成<213> Synthetic
<400> 3<400> 3
ctgacaccta gctgtgatcc tg 22ctgacaccta gctgtgatcc tg 22
<210> 4<210> 4
<211> 228<211> 228
<212> DNA<212>DNA
<213> 人工合成<213> Synthetic
<400> 4<400> 4
ggacaacagt caaacaacaa ttctttgtac tttttttttt ccttagtctt tctttgaagc 60ggacaacagt caaacaacaa ttctttgtac tttttttttt ccttagtctt tctttgaagc 60
agcaagtatg atgagcaagc tttctcacaa gcatttggtt ttaaattatg gagtatgtgt 120agcaagtatg atgagcaagc tttctcacaa gcatttggtt ttaaattatg gagtatgtgt 120
ctgtggagac gagagtaagt aaaactacag gctttctaat gcctttctca gagcatctgt 180ctgtggagac gagagtaagt aaaactacag gctttctaat gcctttctca gagcatctgt 180
ttttgtttat atagaaaatt cagtttcagg atcacagcta ggtgtcag 228ttttgtttat atagaaaatt cagtttcagg atcacagcta ggtgtcag 228
<210> 5<210> 5
<211> 38<211> 38
<212> DNA<212>DNA
<213> 人工合成<213> Synthetic
<400> 5<400> 5
gttttaaatt atggagtatg tttctgtgga gacgagag 38gttttaaatt atggagtatg tttctgtgga gacgagag 38
<210> 6<210> 6
<211> 38<211> 38
<212> DNA<212>DNA
<213> 人工合成<213> Synthetic
<400> 6<400> 6
ctctcgtctc cacagaaaca tactccataa tttaaaac 38ctctcgtctc cacagaaaca tactccataa tttaaaac 38
<210> 7<210> 7
<211> 228<211> 228
<212> DNA<212>DNA
<213> 人工合成<213> Synthetic
<400> 7<400> 7
ggacaacagt caaacaacaa ttctttgtac tttttttttt ccttagtctt tctttgaagc 60ggacaacagt caaacaacaa ttctttgtac tttttttttt ccttagtctt tctttgaagc 60
agcaagtatg atgagcaagc tttctcacaa gcatttggtt ttaaattatg gagtatgttt 120agcaagtatg atgagcaagc tttctcacaa gcatttggtt ttaaattatg gagtatgttt 120
ctgtggagac gagagtaagt aaaactacag gctttctaat gcctttctca gagcatctgt 180ctgtggagac gagagtaagt aaaactacag gctttctaat gcctttctca gagcatctgt 180
ttttgtttat atagaaaatt cagtttcagg atcacagcta ggtgtcag 228ttttgtttat atagaaaatt cagtttcagg atcacagcta ggtgtcag 228
<210> 8<210> 8
<211> 24<211> 24
<212> DNA<212>DNA
<213> 人工合成<213> Synthetic
<400> 8<400> 8
ttacttactc tcgtctccac acac 24ttacttactc tcgtctccac acac 24
<210> 9<210> 9
<211> 25<211> 25
<212> DNA<212>DNA
<213> 人工合成<213> Synthetic
<400> 9<400> 9
tttacttact ctcgtctcca cacaa 25tttacttact ctcgtctcca cacaa 25
<210> 10<210> 10
<211> 23<211> 23
<212> DNA<212>DNA
<213> 人工合成<213> Synthetic
<400> 10<400> 10
tacttactct cgtctccaca caa 23tacttactct cgtctccaca caa 23
<210> 11<210> 11
<211> 22<211> 22
<212> DNA<212>DNA
<213> 人工合成<213> Synthetic
<400> 11<400> 11
acttactctc gtctccacac aa 22acttactctc gtctccacac aa 22
<210> 12<210> 12
<211> 26<211> 26
<212> DNA<212>DNA
<213> 人工合成<213> Synthetic
<400> 12<400> 12
ctttacttac tctcgtctcc acagga 26ctttacttac tctcgtctcc acagga 26
<210> 13<210> 13
<211> 25<211> 25
<212> DNA<212>DNA
<213> 人工合成<213> Synthetic
<400> 13<400> 13
cttacttact ctcgtctcca cagga 25cttacttact ctcgtctcca cagga 25
<210> 14<210> 14
<211> 24<211> 24
<212> DNA<212>DNA
<213> 人工合成<213> Synthetic
<400> 14<400> 14
ctacttactc tcgtctccac agga 24ctacttactc tcgtctccac agga 24
<210> 15<210> 15
<211> 26<211> 26
<212> DNA<212>DNA
<213> 人工合成<213> Synthetic
<400> 15<400> 15
tgaagcagca agtatgatga gcaagc 26tgaagcagca agtatgatga gcaagc 26
<210> 16<210> 16
<211> 23<211> 23
<212> DNA<212>DNA
<213> 人工合成<213> Synthetic
<400> 16<400> 16
ggacaacagt caaacaacaa ttc 23ggacaacagt caaacaacaa ttc 23
<210> 17<210> 17
<211> 24<211> 24
<212> DNA<212>DNA
<213> 人工合成<213> Synthetic
<400> 17<400> 17
ctacttactc tcgtctccac aggc 24ctacttactc tcgtctccac aggc 24
<210> 18<210> 18
<211> 342<211> 342
<212> DNA<212>DNA
<213> 人工合成<213> Synthetic
<400> 18<400> 18
cctccgggaa actgtggcgt gatggccgcg gggctctcca gaacatcatc cctgcctcta 60cctccgggaa actgtggcgt gatggccgcg gggctctcca gaacatcatc cctgcctcta 60
ctggcgctgc caaggctgtg ggcaaggtca tccctgagct gaacgggaag ctcactggca 120ctggcgctgc caaggctgtg ggcaaggtca tccctgagct gaacgggaag ctcactggca 120
tggccttccg tgtccccact gccaacgtgt cagtggtgga cctgacctgc cgtctagaaa 180tggccttccg tgtccccact gccaacgtgt cagtggtgga cctgacctgc cgtctagaaa 180
aacctgccaa atatgatgac atcaagaagg tggtgaagca ggcgtcggag ggccccctca 240aacctgccaa atatgatgac atcaagaagg tggtgaagca ggcgtcggag ggccccctca 240
agggcatcct gggctacact gagcaccagg tggtctcctc tgacttcaac agcgacaccc 300agggcatcct gggctacact gagcaccagg tggtctcctc tgacttcaac agcgacaccc 300
actcctccac ctttgacgct ggggctggca ttgccctcaa cg 342actcctccac ctttgacgct ggggctggca ttgccctcaa cg 342
<210> 19<210> 19
<211> 19<211> 19
<212> DNA<212>DNA
<213> 人工合成<213> Synthetic
<400> 19<400> 19
ggctgtgggc aaggtcatc 19ggctgtgggc aaggtcatc 19
<210> 20<210> 20
<211> 21<211> 21
<212> DNA<212>DNA
<213> 人工合成<213> Synthetic
<400> 20<400> 20
ctccgacgcc tgcttcacca c 21ctccgacgcc tgcttcacca c 21
<210> 21<210> 21
<211> 25<211> 25
<212> DNA<212>DNA
<213> 人工合成<213> Synthetic
<400> 21<400> 21
ccttccgtgt ccccactgcc aacgt 25ccttccgtgt ccccactgcc aacgt 25
<210> 22<210> 22
<211> 21<211> 21
<212> DNA<212>DNA
<213> 人工合成<213> Synthetic
<400> 22<400> 22
tggagtatgt ttctgtggag a 21tggagtatgt ttctgtggag a 21
<210> 23<210> 23
<211> 21<211> 21
<212> DNA<212>DNA
<213> 人工合成<213> Synthetic
<400> 23<400> 23
tggagtatgt gtctgtggag a 21tggagtatgt gtctgtggag a 21
<210> 24<210> 24
<211> 23<211> 23
<212> DNA<212>DNA
<213> 人工合成<213> Synthetic
<400> 24<400> 24
tggagtatgt ttgtctgtgg aga 23tggagtatgt ttgtctgtgg aga 23
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510290700.3A CN104818340B (en) | 2015-05-29 | 2015-05-29 | Detect primer, kit and its PCR method of JAK2 gene V617F loci polymorphisms |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510290700.3A CN104818340B (en) | 2015-05-29 | 2015-05-29 | Detect primer, kit and its PCR method of JAK2 gene V617F loci polymorphisms |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104818340A CN104818340A (en) | 2015-08-05 |
| CN104818340B true CN104818340B (en) | 2018-06-26 |
Family
ID=53728820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510290700.3A Expired - Fee Related CN104818340B (en) | 2015-05-29 | 2015-05-29 | Detect primer, kit and its PCR method of JAK2 gene V617F loci polymorphisms |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104818340B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105441573A (en) * | 2016-01-11 | 2016-03-30 | 武汉海吉力生物科技有限公司 | Primer, probe and kit for detecting mutation of human JAK2 gene V617F |
| CN106086204B (en) * | 2016-07-14 | 2017-08-04 | 上海金域医学检验所有限公司 | The primer and its method of a kind of detection JAK2 V617F gene mutations |
| CN106906299A (en) * | 2017-04-18 | 2017-06-30 | 吉林省锐吉尔生物科技有限公司 | People's JAK2V617F gene mutation detection kits |
| CN110951860A (en) * | 2019-12-23 | 2020-04-03 | 济南金域医学检验中心有限公司 | A method for detecting the mutation rate of JAK2 V617F and its dedicated primers and probes |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1932038A (en) * | 2006-09-27 | 2007-03-21 | 北京大学人民医院 | Method of detecting JAK2V617F mutation and its special primer and TaqMan MGB probe |
| CN103243153A (en) * | 2012-02-10 | 2013-08-14 | 复旦大学附属华山医院 | JAK2 V617F mutation detection application |
| CN103571959A (en) * | 2013-11-04 | 2014-02-12 | 北京海思特临床检验所有限公司 | Primer, probe and kit for detecting gene locus mutation, and using methods |
| CN203530310U (en) * | 2013-11-04 | 2014-04-09 | 北京海思特临床检验所有限公司 | Kit for detecting V617F locus mutation of JAK2 gene |
| CN104531881A (en) * | 2015-01-09 | 2015-04-22 | 湖南圣湘生物科技有限公司 | Fluorescence PCR detection kit for human K-RAS gene mutation |
-
2015
- 2015-05-29 CN CN201510290700.3A patent/CN104818340B/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1932038A (en) * | 2006-09-27 | 2007-03-21 | 北京大学人民医院 | Method of detecting JAK2V617F mutation and its special primer and TaqMan MGB probe |
| CN103243153A (en) * | 2012-02-10 | 2013-08-14 | 复旦大学附属华山医院 | JAK2 V617F mutation detection application |
| CN103571959A (en) * | 2013-11-04 | 2014-02-12 | 北京海思特临床检验所有限公司 | Primer, probe and kit for detecting gene locus mutation, and using methods |
| CN203530310U (en) * | 2013-11-04 | 2014-04-09 | 北京海思特临床检验所有限公司 | Kit for detecting V617F locus mutation of JAK2 gene |
| CN104531881A (en) * | 2015-01-09 | 2015-04-22 | 湖南圣湘生物科技有限公司 | Fluorescence PCR detection kit for human K-RAS gene mutation |
Non-Patent Citations (1)
| Title |
|---|
| 等位基因特异PCR技术的研究与应用;陈吉宝等;《植物遗传资源学报》;20051230;第6卷(第04期);469-473 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104818340A (en) | 2015-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104862402B (en) | Detect primer, kit and its PCR method of ApoE gene pleiomorphisms | |
| CN101824466B (en) | Specific primer, liquid-phase chip and method for SNP detection of CYP2C9 and VKORC1 genes | |
| CN104962609B (en) | Detect primer, kit and its PCR method of CYP2C9 and VKORC1 gene pleiomorphisms | |
| CN101421420B (en) | Mutation detection method and kit used in the method | |
| CN104846106B (en) | Detect primer, kit and its PCR method in BRAF gene V600E mutational sites | |
| CN107119107A (en) | A kind of method and kit for detecting mankind's CYP2C19 gene pleiomorphisms | |
| CN101423866A (en) | PNA, probe, primer and method for detecting K-ras gene mutation | |
| CN107058538B (en) | A kind of primer composition and its composition kit and application | |
| US20130078631A1 (en) | Probe, and polymorphism detection method using the same | |
| CN104894256B (en) | Detect primer, kit and its PCR method of aldehyde dehydrogenase 2 gene rs671 pleomorphism sites | |
| CN104830992B (en) | Detect primer, kit and its PCR method of methylenetetrahydrofolate reductase C677T polymorphic sites | |
| JP2003534812A (en) | Detection of nucleotide sequence variation by restriction primer extension | |
| CN105624296A (en) | Universal fluorescent hairpin primers for detecting gene polymorphism on basis of ARMS (amplification refractory mutation system) fluorescent PCR (polymerase chain reaction) process | |
| CN104818340B (en) | Detect primer, kit and its PCR method of JAK2 gene V617F loci polymorphisms | |
| CN104694622A (en) | Probe for detecting K-ras gene mutation, primer, kit and method | |
| CN104830991B (en) | Detect primer, kit and its PCR method of PDGFRA gene D842V polymorphic sites | |
| US20180187267A1 (en) | Method for conducting early detection of colon cancer and/or of colon cancer precursor cells and for monitoring colon cancer recurrence | |
| CN102317454A (en) | Probe for polymorphism detection of disease-related genes and use thereof | |
| CN104846108B (en) | Detect primer, kit and its PCR method in C-KIT gene D816V mutational sites | |
| CN105567847A (en) | Method for detecting polymorphism rs9005 of human stomach cancer susceptibility gene IL-1RN through MspI | |
| CN110295218B (en) | Method for quantifying mutant allele burden of target gene | |
| CN107937493A (en) | A kind of hair clip Mdification primer for allele PCR | |
| CN112779322A (en) | Gene mutation detection kit based on non-fluorescence labeled probe and high-resolution melting curve, detection method and application thereof | |
| CN104846107B (en) | Detect primer, kit and its PCR method of RET gene M 918T site mutations | |
| CN103103267B (en) | Kit for detecting genotype of human chromosome 21 STR (short tandem repeat) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180626 |